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       The computer-aided detection (CAD) scheme is a developing technology in the medical 
imaging field, and it attracted extensive research interest in recent years. In this dissertation, I 
investigated the feasibility of developing several new novel CAD schemes for different cancer 
research purposes. First, I investigated the feasibility of identifying a new quantitative imaging 
marker based on false-positives generated by a computer-aided detection (CAD) scheme to predict 
short-term breast cancer risk. For this study, an existing CAD scheme was applied “as is” to 
process each image. From CAD-generated results, some detection features were computed from 
each image. Two logistic regression models were then trained and tested using a leave-one-case-
out cross-validation method to predict each testing case's likelihood of being positive in the next 
subsequent screening. This study demonstrated that CAD-generated false-positives contain 
valuable information to predict short-term breast cancer risk. Second, I identified and applied 
quantitative imaging features computed from ultrasound images of athymic nude mice to predict 
tumor response to treatment at an early stage. For this study, a CAD scheme was developed to 
perform tumor segmentation and image feature analysis. The study demonstrated the feasibility of 
extracting quantitative image features from the ultrasound images taken at an early treatment stage 
to predict tumor response to therapies. Last, I optimized a machine learning model for predicting 
peritoneal metastasis in gastric cancer. For this purpose, I have developed a CAD scheme to 
segment the tumor volume and extract quantitative image features automatically. Then, I reduced 
the dimensionality of features with a new method named random projection to optimize the 
model's performance. Finally, the gradient boosting machine model was applied along with a 
synthetic minority oversampling technique to predict peritoneal metastasis risk. Results suggested 
XV 
 
that the random projection method yielded promising results in improving the accuracy 
performance in peritoneal metastasis prediction. 
In summary, in my Ph.D. studies, I have investigated and tested several innovative approaches 
to develop different CAD schemes and identify quantitative imaging markers with high 
discriminatory power in various cancer research applications. Study results demonstrated the 
feasibility of applying CAD technology to several new application fields, which can help 
radiologists and gynecologists improve accuracy and consistency in disease diagnosis and 
















Chapter1:  Introduction 
1.1 Concept and Steps of Computer-aided Detection (CAD) of Medical Images 
Primary studies on computers’ quantitative analysis of medical images were carried out in the 
1960s [1-3]. At that point, it was generally believed that computers could substitute radiologists in 
identifying different abnormalities due to the fact that computers are better than human beings at 
performing particular tasks [4]. Therefore, the concept of computer diagnosis was formed at that 
time. Although researchers achieved impressive results from the initial studies, the first attempts 
to replace radiologists with computers were unsuccessful. The critical reasons for this failure were 
that the advanced image processing techniques and powerful computers were not available at that 
time. A few years later, another approach began in the 1980s, in which the computers’ outputs 
were employed to help radiologists not replace them [4]. Currently, this concept is recognized as 
computer-aided detection and diagnosis (CAD), which has spread extensively. 
To help develop and establish a new paradigm of precision or personalized medicine, the 
development and assessment of CAD schemes have been attracting broad research interest in the 
medical imaging informatics field, which aims to provide clinicians (i.e., radiologists, oncologists, 
and pathologists) the second opinion or decision-making supporting tools to more accurately 
detect, diagnose and/or treat diseases (i.e., cancers) in the clinical practice [5].  
Generally, a typical CAD scheme consists of segmented regions, abnormality detections, and 
the extraction of their unique features for subsequent classification of the problem. CAD schemes’ 
studies have contributed to the automation of these steps, either through improving an existing 
technique or developing a new technique. Several studies have been conducted to improve the 
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CAD system's performance by optimizing its every stage performance. In the following 
subsections, each step of the CAD scheme was described briefly.  
1.1.1 Lesion or ROI Segmentation 
 
Enhancing the accuracy of the segmentation for the region of interest (ROI) in the current CAD 
is one of the hot topics that attract many research interests. Available CAD schemes suffer from a 
technically perfect segmentation step, particularly when the system is trained on a large dataset. 
On the one hand, the segmentation step in the CAD systems cannot be fully automatic since it 
might not be accurate enough to segment all cases in a large dataset correctly. On the other hand, 
manual segmentation would not be the right choice for this kind of data set as it is time-consuming. 
Additionally, if segmentation is not accurate enough, features extracted from the segmented area, 
locally or globally, might not represent the lesions or ROIs. Hence, it would be vital to enhancing 
the accuracy of this step. In paper [6], the authors tried to improve the CAD scheme's segmentation 
and evaluate the performance in predicting short-term breast cancer risk. In this study, the authors 
used bilateral mammographic density asymmetry features of right and left breasts in a large 
dataset. They also proposed a new method for the preprocessing segmentation step. After applying 
the new method, the AUC value increased from 0.63 to 0.70 (Figure 1-1 illustrated the comparison 
of the AUC value of the CAD system before and after applying the proposed segmentation step). 
The results of this study demonstrated the importance of investigating a better segmentation 




Figure 1-1. ROC curve of cancer risk model with and without the proposed segmentation step[6]. 
1.1.2 Feature Extraction 
 
Once tumor regions are defined, imaging features can be extracted. Feature extraction means 
using the most efficient features which can represent valuable information for classification and 
analysis. Therefore, this step plays a critical role in improving the CAD schemes' performance, so 
that numerous studies have been carried out in this area to date.  
Previous CAD mainly used morphological features such as lesion size and shape factors (i.e., 
circularity and boundary speculation), texture patterns (e.g., homogeneous, or heterogeneous), as 
well as features of tumor location and the surrounding tissues (e.g., near the heart) in 2D space [7]. 
While in recent studies, image features of a neighboring voxel in 3D space were introduced. These 
features describe autocorrelation, contrast, correlation, cluster prominence, cluster shade, cluster 
tendency, dissimilarity, energy, homogeneity, maximum probability, the sum of squares, sum 
average, sum variance, sum entropy, or difference entropy.  Besides, gray level run length features, 
derived from run-length matrices. From the gray level run length matrix, features can be extracted 
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describing short and long-run emphasis, gray level nonuniformity, run-length nonuniformity, run 
percentage, low gray level run emphasis, and high gray level run emphasis [7]. 
Radiomics is an emerging field that transforms imaging data into a high-dimensional feature 
space through many automatically extracted data-characterization algorithms. In the paper [8], it 
was hypothesized that radiomic features capture distinct phenotypic differences of tumors and may 
have prognostic power and clinical significance across different diseases. In that study, 440 
radiomic image features were defined that describe tumor characteristics and can be extracted in 
an automated way. The features were divided into four groups: (I) tumor intensity, (II) shape, (III) 
texture, and (IV) wavelet features. The first group quantified tumor intensity characteristics using 
first-order statistics, calculated from the histogram of all tumor voxel intensity values. The second 
group contained features based on the tumor's shape (sphericity or compactness of the tumor). The 
third group included textual features that are able to quantify intra-tumor heterogeneity differences 
in the texture that is observable within the tumor volume. These features were calculated in all 
three-dimensional directions within the tumor volume. Thus, each voxel's spatial location 
compared to the surrounding voxels was taken into account. Forth group features including the 
intensity and textural features extracted from wavelet decompositions of the initial image, thereby 
concentrating the features on different frequency ranges within the tumor volume. Then, feature 
selection based on stability ranks and performance was applied. Four radiomics signature, namely 
(I) ‘Statistics Energy’ describing the overall density of the tumor volume, (II) ‘Shape 
Compactness’ quantifying how compact the tumor shape is, (III) ‘Grey Level Nonuniformity’ a 
measure for intratumor heterogeneity and (IV) wavelet ‘Grey Level Nonuniformity HLH, also 
describing intratumor heterogeneity after decomposing the image in midfrequency, were selected 
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[8]. This study illustrated that applying radiomic features provides an excellent opportunity to 
advance decision-support in cancer treatment. 
1.1.3 Optimal Feature Selection 
 
Since researchers initially use CAD to compute a large number of image features, many of 
them can be redundant (highly correlated) or irrelevant (with lower performance), selecting a small 
set of optimal features is very important. For illustration, in paper [9], the authors investigated a 
new approach to improve feature selection efficiency in developing a CAD scheme. For this study, 
after segmentation of each suspicious lesions, 271 features were extracted categorized in different 
groups consisting of shape, texture, contrast, local topological features, isodensity, speculation, the 
features related to the presence and location of calcifications and fat, as well as texture features 
from the dilated region segments. To select optimal features from this initial large feature pool and 
build an efficient classifier, the authors explored and compared four different feature selection 
methods to optimize an artificial neural network (ANN) based classifier, namely: (1) Phased 
Searching, (2) Sequential Floating Forward Selection (SFFS) method, (3) Genetic Algorithm 
(GA), and (4) Sequential Forward Selection (SFS) method. Results of the four selected methods 
were assessed using a ten-fold cross-validation method. As it can be seen in Table 1-1 among 
these four methods, SFFS has the highest efficiency, which takes 3%–5% of computational time 
and the highest AUC value.  
This study revealed that using a new SFFS based approach significantly improves image 
feature selection efficiency for developing CAD schemes. More importantly, the results of this 
study suggested that choosing an appropriate feature selection method can notably affect the 




Table 1-1. Average AUC results and computation times per fold and corresponding standard 
deviation intervals for the four-compared feature selection and classification approaches 
computed over the tenfold cross-validation experiments. 
No. Method AUC 
Average Computation 
Time per Fold (min) 
1 Phased Searching 0.856 ± 0.029 134.6 ± 3.6 
2 SFFS 0.864±0.034 34.6 ± 1.2 
3 GA_ANN 0.863 ± 0.036 1009 ± 12.4 
4 SFS 0.835±0.02 13.3 ± 1.6 
 
1.1.4 Machine Learning 
 
In medical imaging, machine learning is a technique for identifying patterns and computing 
the image markers, which led to making predictions, detections, risk assessments, and diagnoses 
of interest [10]. The machine learning algorithm then identifies the best combination of the 
extracted image features for the image classifications or computations of some metric for the 
region of interest. Numerous machine learning methods can be used in the medical imaging field, 
each with different characteristics and applications [10-13]. Recently, convolutional neural 
networks (CNN) and deep learning achieved outstanding results in almost all computer vision 
areas. The great advantage of using deep learning is that it does not need identification and 
extraction of image features step; image features are identified in the learning process [10]. 
Machine learning has been used widely in the medical imaging field and will substantially 
influence the future. Computer-aided detection performed using a machine learning algorithm can 
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help clinicians interpret medical imaging findings and reduce interpretation time. As previously 
discussed, machine learning uses image properties and computing features for classifications. A 
recent study [22] authors declared that feature computation is one of the most critical steps of a 
machine learning technique and can highly affect a selected classification model’s accuracy. To 
test the hypothesis mentioned above, the authors evaluate different classifiers' performance after 
applying other feature extraction methods. The results revealed that for specific feature extraction, 
the impact of choosing a classifier is not substantial. However, for a particular classifier selecting 
a proper feature extraction and computation method significantly affects the system's performance.  
Hence, the main focus of all my studies during my Ph.D. was focused on investigating new 
image features, which are considered one of the essential steps of developing a machine learning 
algorithm.  
1.2 Application and Advantages of CAD Schemes 
Over the years, most published CAD research was focused on detecting and diagnosing 
different abnormalities in three organs such as chest, breast, and colon [4]. However, other organs’ 
abnormalities, including liver, brain, and vascular systems, were also subjected to the CAD studies 
[4]. Figure 1-2. depicted 98 developed CAD schemes categorized based on their applications of 
detecting various abnormalities in the recent studies. According to the current research, CAD 




Figure 1-2. Categorized 98 CAD schemes in recent studies based on their applications in 
detecting different abnormalities. 
Additionally, Figure 1-3 shows the number of CAD schemes used for each imaging modality 
among the 98 CAD mentioned above schemes. The results demonstrated that in most studies, CT 





































Figure 1-3. The number of CAD schemes used for different imaging modalities. 
 
In mammography, several studies [15-19] conducting on large datasets ranging from 8,682 to 
115,571 reported that the breast cancer detection rate improved after applying CAD schemes.  
Table 1-2 shows the summary of the results reported in mentioned studies. Moreover, in [19], 
authors noticed that after applying the CAD scheme for small invasive cancers, the detection rate 
increased about 64%.  These results demonstrate the importance of applying CAD schemes to 
assist radiologists in detecting different abnormalities such as breast cancer. 
Furthermore, in the study [20], the authors compared radiologists' accuracy performance with 
and without using the CAD scheme for detecting benign and malignant lung nodules on chest 
radiographs.  As shown in Figure 1-4, the radiologists’ performance was substantially improved 

































Table 1-2. Summary CAD schemes effect in breast cancer detection in previous studies. 
Authors Dataset 
Enhance in 
Recall Rate (%) 
Enhance in Cancer detection rate 
(%) 
Birdwell et al.[17] 8,682 7.6 7.4 
Freer et al.[15] 12,860 18.8 19.5 
Morton et al.[18] 18,096 10.8 7.6 
Cupples et al.[19] 27,274 8.1 16.1 
Gur et al.[16] 115,571 0.1 1.7 
 
 
Figure 1-4. the ROC curves comparing radiologists' performance with and without the CAD 
scheme for detecting chest radiography abnormalities. 
The applications of CAD schemes have also been extended to numerous image analysis 
quantitative techniques, including automatic lesion segmentation, lesion area measurement, and 
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dynamic flow information. These functions may also help clinicians and radiologists with the 
diagnostic examination, treatment set up, treatment response assessment, prognostic, and risk 
prediction for several diseases using image-based features individually or in combination with 
clinical features. After all, CAD schemes for assisting early disease diagnosis in different areas 
can improve treatment therapies and affect higher rates of positive outcomes. 
1.3 Limitations of The Current CAD Development 
Although, in recent years, researchers achieved outstanding results in developing CAD 
schemes, the efficiency of these schemes in helping physicians to improve the detection and 
diagnosis is still a controversial issue. Some studies alleged that the CAD scheme's high false-
positive detection rates substantially reduce the radiologists' efficiency and accuracy [21-23] 
(Figure 1-5). On the other hand, some studies illustrated that radiologists could detect more occult 
cancer if they used the CAD scheme's assistance appropriately [24, 25]. Moreover, a recent study 
revealed that the observers' performance to detect subtle abnormalities was substantially affected 
by the CAD system's performance. The higher the performance of the cueing system, the more 
significant the improvement in the observer’s performance. 
Further, a low-performance cueing system could adversely impact the radiologists’ 
performance to detect suspicious lesions. To clarify, the CAD systems with high false-positive 
results reduce the accuracy of the physicians’ performance, while cueing systems with low false-
positive results improve the radiologists’ performance in detecting abnormalities. Also, the type 






Figure 1-5. The overall accuracy of screening mammography, according to the use of CAD 
systems.[23]  
In addition to the limitations mentioned above, in the following paragraphs, I have mentioned 
some of the significant challenges and difficulties in developing CAD schemes in current studies: 
1. One of the main challenges encountered in CAD schemes' development is that the new 
methods’ results can vary depending on the used datasets. Hence, it is not an easy task to 
determine the effectiveness of a new technique. To establish a technique's reliability, tests 
should be performed with a set of images that preferably have various acquisition 
characteristics. 
2. Another big issue regarding the development of CAD systems is the insufficient 
availability of test images. It is not always viable to access a medical image database 
containing various acquisition characteristics, structures, or abnormalities that a technique 
requires the detection, analysis, or diagnosis of a disease. 
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3. Precise Segmentation of suspicious lesions or regions of interest (ROIs) is also a challenge 
for researchers in CAD schemes’ development. The accuracy of lesion or ROI 
segmentation can affect the accuracy of feature computation and performance of the final 
CAD-generated detection or classification scores. Hence, it is an essential step in 
developing the CAD scheme; however, due to the significant heterogeneity of lesions and 
tissue background, the automatic segmentation of lesions or ROIs is still a difficult task.  
4. Optimal and efficient imaging-based risk factors identified from medical images with CAD 
schemes have been another difficulty of the current CAD schemes. Currently, many 
different image-based risk factor has introduced in several studies. However, improving 
the CAD schemes' accuracy performance by investigating the most efficient risk factor is 
still controversial. 
5. Extracting image markers with high discriminatory power to detect and predict different 
abnormalities is counted as another difficulty of current CAD schemes in recent studies 
since the extracted features from medical images can significantly affect the CAD scheme's 
performance.  
6. In medical images, a large number of image features are calculated from the segmented 
areas (i.e., based on the Radiomics concept). Nevertheless, many of the calculated features 
do not have much discriminatory power and are redundant. Hence, identifying and 
selecting an optimal small set of image features is another challenge facing the performance 
improvement of CAD schemes. 
7. Conventional CAD schemes use a “black-box” type approach, which reduces the users' 
confidence (clinicians) to consider and accept CAD-generated results. To overcome this 
14 
 
issue, it is vital to increase transparency to better understand CAD schemes' reasoning and 
develop interactive CAD tools (or graphic user interface). 
8. Since medical imaging technology is fast-changing, the current paradigm for developing 
CAD systems cannot keep pace with these changes, specifically, as new imaging systems 
are established, where clinical images are insufficient. The ultimate purpose should be 
developing the field to the stage where it will be feasible to model the imaging system’s 
characteristics and model clinicians’ performance. Then, from an array of image 
processing, pattern recognition techniques, and artificial intelligence, choosing a group of 
methods leads to the optimal CAD system. 
Despite the limitations and difficulties of developing and applying CAD schemes in clinical 
practice, many researchers believe that CAD has great potential in future clinical applications, and 
improve its performance and application methods is needed [26]. Thus, CAD remains a very active 
research topic in the medical imaging field, and many advanced or improved technologies have 









Chapter 2: Research Objectives and Hypotheses 
 
2.1 Overall Objectives of Research in This Dissertation  
Previous studies have provided ample scientific data and evidence to support that CAD of 
medical images has broad application potential to provide clinicians (i.e., radiologists and 
oncologists) quantitative decision-making supporting tools for more accurately detecting cancer 
or more effective treating cancer patients. The comprehensive literature search and review during 
my Ph.D. studies have helped me better understand the advantages, progress, and challenges of 
developing and applying CAD schemes of medical images to add more value in various clinical 
application fields. Specifically, I recognize that to make a new and significant contribution in the 
CAD research field, researchers should continue to explore new research ideas for identifying 
application approaches and developing or using advanced image processing and machine learning 
technology to improve and optimize CAD schemes. Thus, the overall objective of my research in 
this Ph.D. dissertation is to explore and investigate three new CAD applications using the novel or 
unique research ideas and/or the advanced image feature processing technology, which include (1) 
identify a new novel CAD-generated risk model to predict short-term breast cancer risk for 
improving the efficacy of breast cancer screening, (2) develop and analyze a quantitative imaging 
marker of ultrasound images to help evaluate and select optimal thermal therapy drugs and 
methods, and (3) investigate and apply a novel random projection algorithm to optimize machine 
learning models for better stratify gastric cancer patients for taking neoadjuvant chemotherapy to 
improve treatment efficacy. The details regarding the motivations and hypotheses of conducting 





2.2 Applying A CAD-Generated Image Marker to Predict Breast Cancer Risk 
2.2.1 Background and Motivation 
Breast cancer causes the highest mortality rate among young women in the United States [27]. 
Previous studies revealed that early detection plays a critical role in reducing the mortality rates 
due to breast cancer [27]. For early detection, mammography is one of the most efficient imaging 
modalities for breast cancer screening [27]. However, the efficacy of current mammogram 
screening is controversial since cancer-detecting yield in the mammography screening 
environment is low [28]. In addition, it also generates high false-positive results. Hence, risk-based 
screening or more accurate prediction models are required to help radiologists better interpret the 
mammography results. Therefore, investigating a better or more accurate and useful risk factor 
makes a considerable contribution to this field, which was my first study's motivation. 
2.2.2 Hypothesis and Scientific Rationale  
Although CAD schemes have been widely used in clinical practices to process screen 
mammograms, they still generate high false-positive results, which reduce radiologists' specificity 
level [29]. In the first study, I hypothesized that we could use these high false-positive results as a 
risk factor; based on the previous studies' findings, which I discuss in the following paragraph. 
Although there are many different risk factors in medical imaging, mammographic density is 
considered a high cancer risk factor in current models [30]. Authors in previous studies declared 
that high mammographic density would lead to high false-positive recalls [31]. On the other hand, 
although a higher false-positive recall rate is one of the significant hurdles that significantly reduce 
the efficacy of mammography screening, previous studies have shown that the false-positive recall 
might be a potential risk factor to indicate the risk or higher probability of cancer detection in the 
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subsequent mammography screening [32, 33]. Thus, in the first study, I hypothesized that CAD-
generated false-positives might not be harmful or only had a negative impact, which may contain 
valuable information. 
2.3 Applying CAD Method to Predict Efficacy of Cancer Treatment 
2.3.1 Background and Motivation  
Currently, imaging plays an essential or determinative role to assess tumor response to the 
treatment, such as using the RECIST guideline to measure the change in tumor size before and 
after treatment. Besides, ultrasound is a low-cost, portable and easy-to-use image modality, which 
has recently emerged as a promising modality for imaging, quantitatively monitoring tissue 
changes, and drug effect over a specific time frame [34]. Using ultrasound imaging modalities to 
identify treatment effects on cancerous cells has been attracting extensive research interest in 
recent years. For this purpose, identification and optimal selection of new biomarkers that have 
high discriminatory power to predict treatments’ results play a crucial role. Thus, the second 
study's motivation was to compute quantitative image features from ultrasound images, which may 
provide useful imaging markers to predict tumor response to treatment or identify more effective 
treatment methods. 
2.3.2 Hypothesis and Scientific Rationale 
In the second study, I hypothesized that by extracting new quantitative image features from 
ultrasound images, we are able to predict the efficacy of cancer treatment at an early stage. In the 
following, I mention the scientific grounds for this hypothesis. 
In previous studies, the efficacy of different treatments has been investigated by extracting 
quantitative features from other imaging modalities such as CT, MRI, X-ray images [35-38]. Those 
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studies have shown that extracting imaging features from those modalities assist clinicians in 
predicting the cancer treatment’s efficacy. On the other hand, recently, ultrasound has been widely 
used to evaluate the treatments’ response to cancerous tumors. However, whether or not the 
extracted features from the ultrasound images can provide any valuable information to assist in 
predicting the efficacy of treatment has not been investigated before my study. Therefore, in the 
second study, I have examined the feasibility of extracting quantitative imaging markers from 
ultrasound images to predict the treatments’ efficacy on cancerous tumors. 
2.4 Exploring New Method to Generate Optimal Features and Improve CAD 
Performance 
2.4.1 Background and Motivation 
Some studies revealed that novel radiomics techniques could extract quantitative information 
from medical images and assist in image interpretation [7, 39-48]. However, CAD schemes are 
initially computing a large number of features, and most of them are highly correlated with lower 
performance. Hence, selecting a small set of features to reduce the feature dimension and enhance 
learning accuracy is fundamental. My third study's motivation was to investigate a new feature 
dimensionality reduction method with higher accuracy performance than the conventional 
methods in the medical imaging field. 
2.4.2 Hypothesis and Scientific Rationale 
Optimal feature dimensionality reduction is essential in improving the performance of the 
machine learning model. In the third study, I hypothesized that applying a random projection (RP) 
feature reduction method would substantially enhance the accuracy performance of machine 
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learning model. The scientific foundation of this hypothesis has been discussed briefly in the 
following paragraph. 
Previously the RP method has been applied in many different image processing tasks and 
computer vision applications [49-51]. Although it has not been used in the medical imaging field 
before my study, it showed promising results in other areas in reducing the features’ dimensionality 
and enhance the accuracy of different models. Therefore, in the third study, I assumed that this 
method could be applied to the medical imaging field and improve the machine learning model's 
performance. 
2.5 Organization of The Dissertation 
This dissertation reports three of my main studies of developing quantitative medical imaging 
analysis that apply different machine learning algorithms (Chapter. 3,4,5,6). In Chapter 3, I have 
conducted a study to take advantage of the false positive generated by the CAD scheme to predict 
short-term breast cancer risk. In Chapter 4, I developed a quantitative ultrasound image feature 
analysis scheme to assess tumor treatment efficacy using a mouse model. In Chapter 5, a random 
projection algorithm was applied to optimize a machine learning model for peritoneal metastasis 
prediction in gastric cancer patients using CT images. Last, in Chapter 6, a summary of these new 
CAD schemes is discussed, which generates this dissertation's conclusion, including this 








Chapter 3: Exploring A New Imaging Marker Generated By 
Computer-Aided Detection Scheme To Predict Short-Term 
Breast Cancer Risk 
3.1 Introduction 
Mammography is one of the most commonly used imaging modalities in population-based 
breast cancer screening to date. However, the efficiency of screening mammography is 
controversial [52] because of the comparatively lower detection sensitivity (particularly among 
women with dense breasts or younger than 50 years old) [53] and higher false-positive recall rates 
[54] with the probable long-term psychosocial consequences [55]. To enhance breast cancer 
screening effectiveness, developing a new and more efficient personalized breast cancer screening 
paradigm has been recently attracting extensive research interest [56]. A prerequisite for realizing 
an optimal personalized screening is recognizing more effective breast cancer risk factors or 
developing more precise risk prediction models to stratify women into two groups with a higher 
and lower risk of having or developing breast cancer in the short-term (i.e., < 1 to 3 years). 
Accordingly, using these risk factors or prediction models may help clinicians or the individual 
patient better decide whether she should currently have more recurrent screening (e.g., annually) 
or be screened at longer intervals until her short-term risk considerably increases in future 
reassessments.  
Although many epidemiological studies based on breast cancer risk prediction models have 
been previously developed and applied to detect high-risk women [30], the models mainly predict 
long-term (or lifetime) risk of subgroups of women comparing to the overall population, which 
have little discriminatory power to determine who should or should not be screened in the short-
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term to help improve the efficiency of breast cancer screening [57]. Consequently, exploring new 
breast cancer risk factors and investigating new breast cancer risk prediction models remains an 
arduous task [58], attracting great research interest and effort. In this field, many researchers 
believe that mammograms consist of significant phenotype markers that can be quantified and 
used to improve the prediction of breast cancer risk [59]. In our previous studies, we investigated 
a new quantitative imaging marker based on the extracted bilateral asymmetry of mammographic 
density features between the left and right breasts. We showed an increasing trend in predicting 
short-term risk or the probability of women having or developing mammography-detectable 
cancers next following mammographic screening [60, 61].  
During our studies of identifying new quantitative imaging features, I recently recognized a 
potential new method. In order to help radiologists reading and interpreting mammograms, 
computer-aided detection (CAD) schemes have been used as “the second reader” in a large number 
of breast imaging clinics since early 2000 [62]. Whether or not using CAD can assist enhance the 
accuracy of radiologists in breast cancer detection is also controversial, primarily because of the 
high false-positive detection rates generated by CAD schemes of mammograms [29]. 
Nevertheless, whether I can apply the quantitative image marker analysis and detection scores on 
the CAD-generated false-positive regions to assist short-term breast cancer risk prediction has not 
been investigated yet. Therefore, I proposed a new hypothesis. Since previous studies have 
indicated that CAD enabled identifying more early abnormalities that were either missed or 
overlooked by radiologists and later became image-detectable cancer [63, 64], the CAD-generated 
false-positives on the negative images may not be completely useless. As a matter of fact, the 
CAD-generated false-positives might contain useful information as quantitative imaging markers 
to assist short-term breast cancer risk prediction. The purpose of this study is to examine our 
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hypothesis using a relatively large and diverse image dataset of 1,044 negative mammography 
screening cases. After using a CAD scheme to process these negative images, I applied a machine 
learning model to explore a new quantitative imaging marker for risk prediction of having 
mammography-detectable cancer at the next subsequent screening (12 to 18 months later).   
3.2 Materials and Method 
3.2.1 Image Dataset 
In this study, I utilized full-field digital mammography (FFDM) images chose from the pre-
existing image dataset in our laboratory, which has been retrospectively assembled in our previous 
studies to develop CAD schemes of mammograms [65, 66] and quantitatively imaging markers 
for breast cancer risk prediction [60, 61]. Briefly, by excluding the interval cancer cases and the 
cases without four images of both the mediolateral oblique (MLO) and craniocaudal (CC) view of 
the right and left breasts, the dataset employed in this study includes FFDM images attained from 
1,044 women who participated in routine annual mammography screenings. Each case had at least 
two or more subsequent FFDM screenings of four view images of both breasts. The latest screening 
is named “current” screening, which can be either positive or negative. All “prior” screenings are 
negative as reported by radiologists in the original image reading and interpretation, which may 
include a small fraction of “false-negative” cases in which the “early suspicious tumors” may be 
considered detectable in the retrospective review [65]. Nonetheless, since these “suspicious 
tumors” were either missed or overlooked by the radiologists in the initial screening, these cases' 
previous images are categorized as negative images in the clinical database. Therefore, the 
negative images used in this study are determined by the clinical record generated from the real 
mammography screening.     
23 
 
From this dataset, I chose images acquired from the first “prior” mammography screening, 
which was taken 12 to 18 months prior to the “current” mammography screening. In the “current” 
screening, 402 cases were positive in which cancer was detected from mammograms and 
confirmed by biopsy, while the rest of 642 cases remained negative (cancer-free) in the “current” 
screenings. Hence, these 1,044 “prior” negative screenings were categorized into two groups of 
the high and low-risk cases. Table 3-1 summarizes the general information of the cases involved 
in our dataset.   
Table 3-1. General information of the image dataset. 
Risk Factor Category High- Risk Cases Low-Risk Cases 
Total Cases  402 642 
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Family History 
No family history 
was known 
Cancers in the 1st-
degree relatives 
Cancers in the 2nd-
degree relatives 














3.2.2 Machine Learning Model 
 
Next, as illustrated in the flowchart of Figure 3-1, the following steps are taken to process each 
image, extract CAD-generated features, and build a machine learning classifier to predict cancer 
risk. First, an existing CAD scheme of mammograms [67] was utilized. The previous study 
revealed that this CAD scheme's performance was quite comparable to two leading 
commercialized CAD schemes in identifying malignant breast lesions using an independent testing 
image dataset to all three CAD schemes under comparison [68]. In brief, the CAD scheme employs 
three stages to detect suspicious mass regions depicting on an image. First, a Gaussian bandpass 
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filter is applied to detect initially suspicious seeds (i.e., typically 10 to 50 per image depending on 
the complexity of breast tissue structure). Second, an adaptive multi-layer topographic region 
growing algorithm is applied to segment each suspicious region. Based on the set of region 
growing criteria, this step typically results in discarding more than 50% of suspicious regions 
initially detected in step one. Third, a multi-feature based artificial neural network (ANN) is 
applied to process each remaining suspicious region and generate a detection score, which 
indicates the likelihood of the detected region associating with a malignant lesion. In this study, I 
applied this CAD scheme of mammograms “as is” to process each FFDM image of all study cases 




Figure 3-1. Flowchart showing the steps of applying the proposed image processing and risk 
prediction scheme. 
Second, I summarized CAD-generated detection results and scores on all detected suspicious 
regions on each image. First, four features were computed, which are (1) the number of initial 
suspicious seeds detected by the first step of the CAD scheme, (2) the number of final suspicious 
mass regions detected by the second step of the CAD scheme, (3) total (summation) score of all 
27 
 
detected suspicious mass regions, and (4) average score of all detected suspicious mass regions. 
Second, I computed bilateral summation between two left and right (CC or MLO view) images. In 
this way, I generated a total of eight features, namely four for the CC view and four for the MLO 
view images. Third, I computed the mean value (𝜇) and standard deviation (𝜎) of each feature 
computed from all 1044 testing cases. Each feature was then normalized to a range from 0 to 1 
(within 𝜇 ± 2𝜎). All outliers were assigned to either 0 or 1 depending on whether their actual value 
is smaller than zero or greater than one.  
Third, since a mammogram is a two-dimensional projection image overlapped with fibro-
glandular tissues along the projection direction, mammographic tissue patterns or image features 
computed from the CC and MLO view of one breast may vary significantly. Thus, I separately 
built two classifiers that combine the four bilateral summation features computed from either CC 
or MLO view images to stratify the testing cases into the high and low-risk classes of having 
mammography-detectable cancers in subsequent mammography screening. Despite the fact that 
many different machine learning classifiers can be used for this purpose, I selected a multinomial 
logistic regression model based classifier because it is inherently simple, low variance, fast in 
training, and has a lower probability of overfitting.  
Fourth, in order to build the classifier, I used a Weka data mining and machine learning 
software platform [68], which has been successfully applied and tested in a number of our previous 
studies in developing multi-feature fusion based machine learning classifiers to predict cancer risk 
and prognosis [69-71]. In order to minimize the case selection or partition bias, I applied a leave-
one-case-out (LOCO) based cross-validation method to train and test the classifier [72] in which 
a classifier was trained using 1,043 cases and tested using one remaining case. Thus, through 1,044 
training and testing iterations for each classifier, each case (either two bilateral CC view or MLO 
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view images) had a CAD-generated independent classification score ranging from 0 to 1. The 
higher score indicates the higher risk or likelihood of the study case having or developing 
mammography-detectable cancer in a short-term, defined as occurring 12 to 16 months later.  
Last, I conducted the following data analysis tasks to assess the performance of using the new 
risk prediction models for case stratification. I used a receiver operating characteristic (ROC) 
based data analysis method. A maximum likelihood-based ROC curve fitting program (ROCKIT, 
http://xray.bsd.uchicago.edu/krl/roc_soft.htm) was used to generate the ROC curve and compute 
the area under the curve (AUC). I also applied an operating threshold (T = 0.5) on the classification 
scores to divide the cases into two groups and generated the corresponding confusion matrix. I 
then computed the odds ratio (OR) from the confusion matrix. The adjusted odds ratios and their 
increasing trend were also computed and analyzed using a statistical software package (R version 
2.1.1, http://www.r-project.org). The data analysis results were tabulated and compared.  
3.3 Results 
Figure 3-2 shows an example of applying our CAD scheme to process four bilateral CC and 
MLO view images of a “prior” mammography screening case. Table 3-2 summarizes the 
computed four features and detection scores for all suspicious regions detected by the CAD scheme 
on four view images of this testing case. In this case, CAD initially detected 81 (ranging from 14 
to 23) seeds for the suspicious lesions in the first step. After applying the second step of region 
growing algorithms, the suspicious mass numbers were reduced to 32 suspicious regions detected 
in four images. In the third step of the CAD scheme, an artificial neural network-based classifier 
generated a detection score for each of 32 regions, which indicates the likelihood of the region 
associated with a positive mass. Thus, unlike a conventional CAD cueing method used in the 
clinical practice, which only cues the regions with detection scores greater than a predetermined 
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threshold, all 32 suspicious regions are cued in Figure 3-2, and all detection scores reported in 
Table 3-2 were extracted and used to build the prediction model. All 32 CAD-generated cueing 
markers were discarded as false-positives, and the case was classified as a negative case. The 
radiologists detected a malignant mass-type lesion in the subsequent mammography screening, as 
shown in Figure 3-3. Comparing images in Figures 3-2 and 3-3, I observed that the lesion detected 
in “current” images is not “visible” in the “prior” images. However, CAD has two cueing markers 
with detection scores of 0.56 and 0.65 (as shown in Table 3-2) on the left MLO view “prior” 
images (Figure 3-2), which seems to match with the region that has malignant mass detected in 







Figure 3-2. An example showing CAD processing results in one testing case of four bilateral CC 
and MLO view images. The top row shows four original images, and the bottom row shows 






Figure 3-3. A malignant lesion was detected in the CC and MLO views of the left mammogram 
(as pointed by the arrow) in the next subsequent (“current”) screening of the same case as shown 




Table 3-2. Summary of CAD-detection result and computed four features from one example of 
mammography screening case. 
Image View CC (left) CC (right) MLO (left) MLO (right) 
Detected regions 8 8 8 8 
Average score 0.47 0.38 0.48 0.38 
Total score 3.74 3.01 3.82 3.05 
Initial suspicious seeds 23 14 22 22 
Detailed detected 
regions and their scores 
1) 0.44 1) 0.41 1) 0.27 1) 0.34 
2) 0.34 2) 0.39 2) 0.31 2) 0.31 
3) 0.50 3) 0.66 3) 0.56 3) 0.54 
4) 0.46 4) 0.27 4) 0.65 4) 0.19 
5) 0.32 5) 0.34 5) 0.38 5) 0.41 
6) 0.51 6) 0.31 6) 0.55 6) 0.26 
7) 0.52 7) 0.28 7) 0.40 7) 0.44 
8) 0.66 8) 0.37 8) 0.70 8) 0.58 
 
Two logistic regression model based classifiers trained using CC and MLO view images 
yielded areas under ROC curves, AUC= 0.5861±0.0181 and AUC= 0.6521 ± 0.0176, to predict 
cancer risk, respectively. It shows that using CAD-generated detection results or features 
computed from bilateral MLO view images yielded higher prediction performance than using 
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bilateral CC view images (p < 0.05). Figure 3-4 shows the ROC curve of applying the logistic 
regression model based classifier to MLO view images. 
 
Figure 3-4. The ROC curve for MLO view with an AUC value of 0.6521 ±0.017.  
Table 3-3 shows a confusion matrix of using CAD-generated detection scores on the bilateral 
MLO view images, generated by applying an operation threshold of T=0.5 on the risk prediction 
score. Using this operation score, the risk prediction sensitivity is 27.6%, and the specificity is 
88.0%. Table 3-4 summarizes the correspondingly computed odds ratio and risk ratio with their 
95% confidence intervals. Table 3-5 reports the adjusted odds ratios, which were computed after 
applying a set of thresholds to automatically divide 1,044 cases into five subgroups with an 
approximately equal case number. The risk prediction scores gradually increase from subgroup 
one to five. Using subgroup one as a reference (baseline) with 208 cases, the adjusted odds ratios 
and 95% confidence intervals for subgroups two to five with 209 cases were computed. The 





























Fraction of False Positive
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6.83]. Using regression analysis, the regression line's slope generated from the adjusted odds ratios 
is significantly different from the zero slopes (p < 0.01), which indicates an increasing trend of the 
adjusted odds ratios with an increase of risk prediction scores.    
Table 3-3. The confusion matrix of using CAD generated detection results on bilateral MLO 
view images. 
 Actual Positive Actual Negative 
Predicted Positive 111 77 
Predicted Negative 291 565 
 
Table 3-4. The odds Ratio and Risk Ratio of using CAD generated detection results on bilateral 
MLO view images. 
Significance Level 95% 
Odds Ratio 2.03 < 2.80 < 3.87 
Critical Odds Ratio (COR) 1.11 






Table 3-5. The adjusted Odds Ratio and 95% confidence interval using risk prediction scores 










1 51 157 1 N/A 
2 55 154 1.09 0.71 – 1.71 
3 80 129 1.91 1.25 – 2.91 
4 92 117 2.42 1.59 – 3.68 
5 124 85 4.49 2.95 – 6.83 
 
3.4 Discussion 
The impact of false positives on the subsequent risk of breast cancer has been previously 
investigated. For example, one study reported that women undergoing false-positive 
mammography at the first screening were less likely to participate in subsequent screenings, yet 
were more likely to develop interval cancers or cancers at subsequent screening [73]. Another 
study reported that women having false-positives involving fine-needle aspiration cytology or a 
biopsy had a higher breast cancer detection risk than those involving additional imaging 
procedures alone in subsequent screening participants over 17 years. The odds ratios ranged from 
1.81 to 2.69 [33]. This study provided new evidence and experimental data regarding the possible 
association between false-positives and cancer detection risk in the subsequent screenings. Unlike 
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previous studies using qualitative assessment, our approach aims to explore, identify and/or 
develop a new quantitative imaging marker based on CAD-generated false-positive detection 
results to help predict short-term breast cancer risk.    
 Since CAD schemes of mammograms are currently available and used in clinical practice, 
extracting a new quantitative imaging marker from CAD findings in the “current” negative images 
is a more efficient and cost-effective approach to help predict the short-term risk of breast cancer 
detection in the subsequent screenings, which does not require additional imaging or genomics 
tests. Since the dataset used in this study was initially assembled for developing CAD schemes, it 
is not an age-matched dataset (as shown in Table 3-1) and thus includes a large fraction of difficult 
negative cases of younger women with dense breasts [60, 65]. Thus, applying the CAD scheme to 
this dataset tends to produce more false-positive detections, as indicated in the previous study [68]. 
However, despite using this relatively challenging dataset, the result of the risk prediction in this 
study is encouraging, which yielded an odds ratio of 2.80 (as shown in Table 3-4) or the maximum 
adjusted odds ratio of 4.49 (as shown in Table 3-5). The odds ratio is higher than or quite 
comparable to many existing risk factors reported in previous breast cancer risk prediction studies 
[30, 33, 73]. Thus, this study identified a potential new clinical application for CAD schemes of 
mammograms. The study also indicated that further exploration is worth optimizing this new 
CAD-based imaging marker in future studies.  
In this study, I also had several specific observations. First, although CC and MLO view 
mammograms provide complementary information and reading mammograms of both views can 
help detect more cancers and reduce false-positive recalls [74], CAD results on two bilateral CC 
and MLO view images were highly correlated. In this dataset, CAD results on MLO images 
yielded higher risk prediction performance. AUC value for using CAD-generated results on MLO 
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view images was 0.652±0.017 with 95% CI of [0.617, 0.686] while using CAD results on CC view 
images, AUC value was 0.586±0.018 with 95% CI of [0.550, 0.621]. The computed correlation 
coefficients are 0.75 for all classification scores of 1,044 cases (or 0.76 and 0.73 for 402 high-risk 
and 642 low-risk cases, respectively). Thus, due to the higher correlation coefficient of CAD-
generated detection results between using bilateral CC and MLO view images, using the 
conventional fusion methods [75, 76] was unable to further increase AUC value beyond that 
yielded using MLO view images. To clarify, using an average fusion method yielded AUC=0.631± 
0.018.    
Second, previous studies have reported that in the retrospective review of the positive cases' 
prior images, a large fraction of subtle or occult “early tumors” can be detected by radiologists. 
Thus, in developing the conventional CAD schemes of mammograms, these missed or overlooked 
“early tumors” by the radiologists in the real screening environment are typically considered “false 
negative” cases and selected as positive training cases to increase CAD sensitivity to detect more 
subtle tumors. In this study, I also conducted a test by removing 53 cases in which the “early 
masses” were considered “visible” or detectable in our previous retrospective review [65]. After 
removing these cases, the computed AUC value remained relatively constant with only a slight 
change (or increase) from 0.652±0.017 to 0.659±0.018. The results suggest that unlike the task to 
develop the conventional CAD schemes of mammograms, for this new specific task of predicting 
the risk of having mammography-detectable cancer in the subsequent (or annual) screening, the 
negative case group should include all cases that were determined as negative in the real 
mammography screening environment (include those potential “false negative” cases). More 
accurately predicting the risk of cancer detection in the next annual screening of these “false 





I investigated and demonstrated the feasibility of extracting a new quantitative mammographic 
imaging marker from the existing CAD-generated false-positives on the negative mammograms 
to help predict cancer detection risk in the next subsequent mammography screening. This new 
imaging marker or risk prediction model's discriminatory power is higher than or quite comparable 
to many other breast cancer risk factors reported in the literature and/or used in many epidemiology 
studies based on breast cancer risk prediction models. In addition, since commercialized CAD 
schemes of mammograms are currently available and used in the clinical practice, computing and 
utilizing this new imaging marker, if successful in the future validation of the prospective studies 
using the large and diverse databases, is a cost-effective approach to help improve the efficacy of 










Chapter4: Developing A Quantitative Ultrasound Image Feature 
Analysis Scheme To Assess Tumor Treatment Efficacy Using A 
Mouse Model 
4.1 Introduction 
Before performing clinical trials on cancer patients, mouse models are frequently used as an 
essential step in biomedical research to screen and test new investigative chemotherapy drugs 
and/or therapeutic methods in order to identify effective drug agents, drug delivery methods, and 
other treatment technologies for improving the efficacy of cancer treatment [77]. The advantages 
and necessity of applying mouse models in the initial steps of developing new drugs and/or cancer 
treatment methods have been extensively investigated and discussed in previous studies [78, 79]. 
As a result, a large number of mouse models bearing different types of simulated carcinoma tumors 
have been developed and used in the cancer research field [80-82].  
In order to non-invasively visualize and characterize tumor response and/or tissue changes 
during and/or after cancer treatment, medical imaging plays a vital role by helping validate certain 
study hypotheses [83]. Many imaging modalities, such as x-ray imaging, including micro-
computed tomography (µCT), magnetic resonance imaging (MRI), nuclear and optical imaging, 
and ultrasound imaging, have been proposed and used for this purpose in recent years [84-86]. 
Each imaging modality has its specific features and limitations in predicting or assessing tumor 
response efficacy to the treatment. Compared to other imaging modalities, ultrasound has a number 
of unique characteristics, making it a more attractive tool to predict or assess cancer prognosis to 
some clinicians. It is a portable, safe (no harmful radiation), easy-to-use, and low-cost imaging 
modality to monitor and assess tumor response and tissue characteristics change prior to and post-
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treatment [34, 87]. However, despite the potential advantages of using ultrasound imaging to 
assess treatment efficacy, ultrasound often includes higher noise resulting in a relatively low 
signal-to-noise ratio. Reliably detecting and computing quantitative image features of tumors from 
ultrasound images is considered more difficult than computing image features from other imaging 
modalities (i.e., µCT and MRI). As a result, the feasibility of developing or identifying new 
quantitative imaging markers computed from ultrasound to predict or assess cancer treatment 
efficacy at an early stage has not been investigated and validated to date. 
Thus, based on the concept and scientific premise of Radiomics [88], the objective of this study 
is to test the feasibility of identifying and extracting new quantitative image features or markers 
computed from ultrasound images to predict the efficacy of cancer treatment at an early stage. In 
order to achieve the study objective, I developed an interactive computer-aided detection (CAD) 
scheme with an easy-to-use graphic user interface (GUI) to process ultrasound images acquired 
from the colon carcinoma tumor bearing mice treating with a variety of thermal therapies. The 
CAD scheme computes a large pool of image features based on tumor morphology, density 
distribution, and texture-related features from the segmented tumor regions depicted on the 
ultrasound images. Data analysis was then performed to identify top image features and their 
fusion method to generate new quantitative imaging markers to predict and compare the efficacy 






4.2 Materials and Methods 
4.2.1 Image Dataset 
 
In this study, I assembled an experimental dataset that includes 23 athymic nude mice bearing 
C26 adenocarcinomas. These mice were treated with seven different thermal based therapies that 
combine the focused ultrasound-induced mild hyperthermia and chemotherapeutic nanoparticle 
formulations. Specifically, these seven treatment methods include (1) high intensity focused 
ultrasound (HIFU), (2) the chemotherapeutic drug doxorubicin (DOX), (3) DOX and HIFU, (4) 
low-temperature sensitive liposomes (LTSL), (5) HIFU and LTSL, (6) echogenic low-temperature 
sensitive liposomes (E-LTSL), and (7) HIFU and E-LTSL. Both LTSL and E-LTSL are different 
nanoparticle formulations that encapsulate DOX. The details of these treatment methods have been 
previously reported [89].  
In brief, HIFU is a non-invasive therapeutic technique that uses focused ultrasound energy to 
heat a targeted region of tissue in a controlled manner. DOX is a commonly administered, 
clinically available chemotherapeutic drug, which is often used for treating a wide range of 
different cancer types. The addition of HIFU hyperthermia increases blood flow to the tumor 
region and increases drug perfusion in a targeted manner. LTSLs are thermosensitive liposomes 
that carry a DOX payload to the tumor site; should heating be applied via HIFU (39-42⁰C), DOX 
will be released at the tumor site, granting the DOX an additional degree of targeting effect. E-
LTSLs have the same lipid composition as the aforementioned LTSL and incorporate an 
ultrasound contrast agent that becomes echogenic (visible on ultrasound) during HIFU heating.  
They also have the added advantage of promoting improved drug penetration via 
HIFU/nanobubble interaction.  
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In the mouse model used in this study, all animal-related procedures were approved and carried 
out under the guidelines and regulations of the Oklahoma State University Animal Care and Use 
Committee (ACUP VM-13-24). Specifically, in order to establish a mouse model of colon cancer, 
C26 cells were grown as a monolayer to 80–90% confluence in RPMI supplemented with 10% v/v 
fetal bovine serum (FBS) and 1% v/v streptomycin/penicillin. Confluent cells were harvested, 
washed, and diluted with sterile, cold PBS to generate 0.5 × 105 cells/50 μl. Next, 50 μl of cell 
inoculum was injected per mouse in the thigh region of the mouse hind leg using a 25-gauge needle 
(BD, Franklin Lakes, NJ, USA). Mice were monitored, and tumor growth was measured by serial 
caliper measurements (General Tools Fraction+™, New York, NY, USA). Tumor volumes were 
calculated using the equation of (length X width2)/2, where length is the largest dimension and 
width is the smallest dimension perpendicular to the length. After three days, tumors typically 
grow and reach a treatment volume of greater than 50mm3 [89].  
In this study, each mouse was treated twice using the targeted thermal therapy on Day 3 and 
Day 6 after the cell inoculum was injected, respectively. The longitudinal ultrasound images were 
taken prior to and post-treatment in these two days using a Vevo 2100 ultrasound imaging system 
at a frequency of 21 MHz [89]. During the process, mice were anesthetized and held in custom-
built mouse holders attached to a 3D positioning stage, and the tumors were positioned so that the 
target was in the center of the focal zone of the ultrasound imaging transducer. In each image 
acquisition process, multiple ultrasound image frames or a series of imaging videos were taken 
and recorded. Each mouse was monitored for ten days. On Day 10, the mouse was sacrificed. The 




4.2.2 Developing CAD Scheme 
 
In this study, I developed an interactive computer-aided detection (CAD) scheme with a 
graphic user interface (GUI) platform. Following three steps were taken to perform image 
processing and feature computation. First, after uploading a complete set of ultrasound imaging 
video series into the GUI, the operator (i.e., a research assistant in the study laboratory) selects one 
ultrasound image (representing the best frame in the video) in which the tumor area is considered 
clearly visible. The tumor region is then segmented manually from the ultrasound image. Figure 
4-1 illustrates an example of the tumor regions and their boundary contours segmented from 4 sets 
of ultrasound images acquired from one mouse prior and post-DOX treatment on Day 3 and Day 
6 using the GUI of our CAD scheme, respectively. Specifically, I used the algorithm illustrated in 



































Figure 4-1. An example of four ultrasound images taken from a mouse in Day 3 (A) prior- DOX 
treatment and (B) post-treatment, in Day 6 (C) prior-treatment and (D) post-treatment, 
respectively. The tumor boundary contours are marked on each image. 
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Figure 4-2. Proposed Algorithm for processing each image. 
4.2.3 Feature Extraction 
 
After tumor segmentation, the CAD scheme applies a low pass Gaussian filter on images to 
decrease the ultrasound images' inherent noise (Figure 4-3). CAD then computes image features. 
A total of 284 image features are computed from each segmented tumor region. Similar tumor-
related image features have been computed from other imaging modalities (i.e., CT and MRI) in 
our previous studies to develop quantitative image markers for predicting tumor response to 
chemotherapies of treating breast and ovarian cancer [70, 90]. These features can be categorized 
into four groups as summarized in Table 4-1, which include (1) nine morphology-based image 
features; (2) 21 tumor density distribution related image features; (3) 44 grayscale run length 
(GSRL) based texture related image features [91], which include (a) Short Run Emphasis (SRE), 
(b) Long Run Emphasis (LRE), (c) Gray-Level Nonuniformity (GLN), (d) Run Length 
Nonuniformity (RLN), (e) Run Percentage (RP), (f) Low Gray-Level Run Emphasis (LGRE), (g) 
High Gray-Level Run Emphasis (HGRE), (h) Short Run Low Gray-Level Emphasis (SRLGE), (i) 
Short Run High Gray-Level Emphasis (SRHGE), (j) Long Run Low Gray-Level Emphasis 
(LRLGE), and (k) Long Run High Gray-Level Emphasis (LRHGE) computed in four different 
directions (0°, 45°, 90°, and 135°), respectively; and (4) 210 image features computed from the 
wavelet transformation maps. Appendix Ι illustrated features’ computations.  
 
I=Total frames 
 For (i=1: number of total frames) 
        J=Selected frame by the operator 











Figure 4-3. Illustration of applying Gaussian filter to the ultrasound image, which shows (A) 
manually marked tumor boundary contour, (B) the segmented tumor region, and (C) tumor 










Morphology  1-9 Volume, convexity, maximum radius, radius standard 
deviation (STD), surface area, compactness, maximum 
three-dimensional diameter, spherical disproportion, and 
spherical ratio. 
Density 10-30 Density, density STD, gradient mean, gradient STD, ISO-
intensity, fluctuation mean, fluctuation STD, mean 
contrast, contrast, skewness, kurtosis, STD ratio of tumor 
to the boundary, energy, entropy, maximum intensity, 
mean absolute deviation, median, minimum, range, RMS, 
and uniformity. 
Texture 31-74 11 gray-level run length-based features in four directions 
(0°, 45°, 90°, and 135°). 
Wavelet 75-284 Apply the density and texture features to the four wavelet 
decompositions. 
 
Precisely, to compute image features in group four, CAD applies the wavelet transform on the 
ultrasound image so that the image is decomposed into four components, including ILL, ILH, IHL, 
and IHH, where H and L are labeled as the high- or low-scale decomposition in either the X or Y 
direction. Intrinsically, in this computation, IHL denotes the component after applying the high-
scale and low-scale filter along with the X and Y directions, respectively. For each component, the 
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density and texture features measured in the second and third group are recalculated, respectively. 
Figure 4-4 shows a two-step algorithm to filter images and compute image features.  
After image processing and feature computation, I assembled four initial image feature pools, 
which include the image features computed from (1) prior treatment on Day 3, (2) the difference 
between prior and post-treatment on Day 3, (3) prior treatment on Day 6, and (4) the difference 
between prior and post-treatment of Day 6. Afterward, all computed features in each feature pool 
were normalized to the values between 0 and 1. Hence, two initial feature pools were established 
for each thermal treatment on Day 3 or Day 6. The first one includes image features extracted from 
prior treatment ultrasound images only, and the second one includes image feature difference by 
subtraction between two features computed from the two matched images acquired prior and post-
thermal therapy of the same mouse.  
 
Figure 4-4. The proposed algorithm for image filtering and feature computation. 
 
In order to identify and select the potentially effective quantitative image features or markers, 
I used tumor size change during the period of starting tumor treatment (Day 3) to the end of 
monitoring (Day 10) as a comparison reference (“ground-truth” of treatment efficacy) in this study.  
Specifically, the tumor size increment ratio (TSIR) for each mouse is computed with the Formula 




∗ 100                                                                                                                               (4-1) 
J´´=Low pass Gaussian filter (J´) 
Feature_vector = CAD(J´) 
49 
 
where x1 and x2 are the mouse tumor size at day 3 and day 10, respectively. This TSIR based 
evaluation criterion is similar to Response Evaluation Criteria in Solid Tumors (RECIST) 
guidelines used in current clinical practice to assess tumor response to therapies among cancer 
patients [92]. Then, the computed TSIRs were normalized between 0 and 1. Figure 4-5 shows the 
















Figure 4-5. Distribution of the normalized TSIR ratios based on (A) each mouse and (B) average 
of each therapy group. 
In order to identify the association between the image features and treatment efficacy, I 
computed the correlation coefficient of each feature with TSIR using the following equation [80]:  
𝑟 =
𝑛(∑ 𝑥𝑦)−(∑ 𝑥)(∑ 𝑦)
√[𝑛 ∑ 𝑥2−(∑ 𝑥)2][𝑛 ∑ 𝑦2−(∑ 𝑦)2]
                                                                                                 (4-2) 
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where “r” is the Pearson correlation coefficient, “x” and “y” are one selected image feature and 
the TSIR, respectively. “n” is the case study size, which is 23 in this study. Interpretation of the 
computed Pearson’s Correlation coefficient to the association between two compared parameters 
(i.e., one image feature and TSIR in this study) is listed in Table 4-2 [93]. Thus, the image features 
that have higher Pearson’s correlation coefficients with TSIR indicate the higher performance to 
predict treatment efficacy in this study. 
Table 4-2. Pearson Correlation coefficient interpretation [55]. 
“r “ Value Relation 
+0.70 or higher (-0.70 or lower) 
Very strong positive (negative) 
relationship 
+0.40 to +0.69 (-0.40 or -0.69) Strong positive (negative) relationship 
+0.30 to +0.39 (-0.30 or -0.39) Moderate positive (negative) relationship 
+0.20 to +0.29 (-0.20 or -0.29) Weak positive (negative) relationship 
+0.01 to +0.19 (-0.01 or -0.19) No or negligible relationship 
0 No relationship [zero correlation] 
 
By computing Pearson’s correlation coefficients of 284 image features stored in each of the 
four initial feature pools representing the ultrasound imaging tests performed on Day 3 and Day 6, 
I first selected the top five image features that have a higher correlation with TSIR in each feature 
pool. Next, I calculated the correlation coefficient of these five features with each other. Then, in 
order to reduce redundancy, I selected two features among these five top features, which have the 
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lowest correlation coefficient, to generate a new fusion marker using an equally weighting method, 
𝐹𝑛𝑒𝑤 = (𝐹1 + 𝐹2) 2⁄ . A similar fusion method has been used in our previous studies (i.e., [94]). 
I also recognize that unlike other imaging modalities (i.e., CT or MRI), an ultrasound imaging 
test usually acquires multiple image frames. In this study, one ultrasound imaging test or scan 
typically includes up to 200 image frames. In order to test the scientific rigor or reproducibility of 
the quantitative image features computed from different ultrasound image frames, I defined one 
frame initially selected by the operator of the GUI of our CAD scheme as the base frame of a set 
of ultrasound images acquired in one test. I also processed and computed the same image features 
of the segmented tumor region from all other ultrasound image frames (i.e., the remaining 199 
frames) in this set. Then, I computed the mean correlation coefficient and the standard deviation 
of the features computed from the base frame and all other 199 frames. Figure 4-6 shows an 
algorithm to examine the reproducibility of the features computed from the base frame as 
compared to the features computed from all other frames. 
Figure 4-6. The proposed algorithm for examining reproducibility or consistency between the 




N=Manual segmentation on frames 
base_feature_vector=CAD(N) 
      For=j: total number of frames 
             N´=map segmentation of N on frame (j) 
             N´´=correction(N´) 





Table 4-3 shows two sets of five optimal image features with the highest Pearson correlation 
coefficients with the treatment outcome (TSIR) and the corresponding p-values. These features are 
selected from the two initial image feature pools that record the image features computed from the 
ultrasound images acquired prior treatment on Day 3 and Day 6, respectively. It shows that using 
image features computed from prior treatment ultrasound images acquired on Day 3 yielded a 
moderate correlation, and there are no significant differences between the top five features (p > 
0.05) while using the image features computed from prior treatment ultrasound images acquired 
on Day 6 increase the correlation level to a strong positive correlation and the number one feature 
yielded significantly higher correlation as compared to other four top features (p < 0.01).  
The top five performed image features selected on Day 3 and Day 6 are different, as shown in 
Table 4-3, which indicates that treatments have an impact on the change of tumor morphological 
and texture characteristics. In addition, Table 4-4 shows and compares five sets of correlation 
coefficients of the same image features computed from prior treatment ultrasound images acquired 
on both Day 3 and Day 6.  
The results show that image features contain increased discriminatory power or higher 
correlation coefficients as they approach the endpoint of Day 10 (i.e., Day 6 vs. Day 3) to predict 






Table 4-3. List of two sets of the selected 5 top image features from 2 image features of prior 
treatment on Day 3 and Day 6. 
Day 3  Day 6  












Range 0.375  GLN HL 0.680  
Entropy HH 0.361 0.468 RP HL 0.643 <0.01 
RP LL 0.359 0.415 GLN HL 90° 0.605 <0.01 
Entropy LL 0.355 0.478 RLN LL 0.598 <0.01 
GLN HL 90° 0.344 0.377 Entropy HL 0.597 <0.01 
  
Table 4-4. Comparison of the correlation coefficients of the same image features computed from 
prior treatment ultrasound images acquired on Day 3 and Day 6. 
 GLN HL 90° Tumor Vol. RLN HL RP HH 90° GLN LL 
Day3 0.344 0.341 0.329 0.326 0.318 
Day6 0.605 0.525 0.586 0.546 0.551 
   
Table 4-5 shows the correlation coefficients between TSIR and five top image features 
selected from the feature pool that contains image feature differences computed between prior and 
post-treatment ultrasound images acquired on Day 3. It shows that using the image features that 
represent the difference in tumor response or characteristic change prior and post-therapies yields 
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a higher correlation with TSIR or higher prediction power. In addition, by selecting two of the five 
top features (as listed in Table 4-5), which have the smallest correlation coefficients among the 
five top features, I applied an equally weighted fusion method to generate a new image marker. 
The correlation coefficient of this new fusion-based image marker and TSIR significantly 
increased to 0.679, as shown in Table 4-5. 
Table 4-6 shows the five selected image features computed from the differences between the 
prior and post-treatment ultrasound images acquired on Day 6 with the highest correlation 
coefficients to TSIR. However, when comparing the correlation coefficients of the top five-  
Table 4-5. List of the five selected image features computed from the difference of prior and 
post-treatment ultrasound images acquired on Day 3 with the high correlation with TSIR. 
No. Features 
Correlation 
coefficient with TSIR 
P-value comparing to F1 
F1 GLN HL 0.552  
F2 LGRE 0° 0.495 0.128 
F3 Range HL 0.388 0.011 
F4 LGRE LL 0.387 0.530 
F5 Gradient STD LH 0.373 0.809 




features computed from prior treatment ultrasound images acquired on Day 6 (Table 4-3), 
correlation coefficients decrease, which indicates that adding the image features computed from 
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post-treatment ultrasound images on Day 6 does not help increase power to predict treatment 
outcome (TSIR determined on Day 10).  
Table 4-6. The top image features were computed from the difference of prior and post-treatment 





to RLN HH 45° 
RLN HH 45° 0.428  
RLN HH 135° 0.420 <0.01 
RP HH 90° 0.358 <0.01 
RP HH 0.357 <0.01 
LGRE LL 0.306 0.251 
     
Subsequently, I separately analyzed and sorted feature distribution in seven groups of different 
thermal therapy methods. Each of the seven treatment groups involves 2 to 4 mice. For example, 
Figure 3-7 shows the distribution (or boxplot) of one of the top image features (the GLN HL values) 
computed from the difference of prior and post-treatment ultrasound images acquired on Day 3 
across the treatment groups. The result shows a trend indicating that the image feature values vary 
when using different thermal therapy methods. Finally, Table 3-7 shows examples of the mean 
correlation coefficient, standard deviation, and 95% confidence interval of the base frame and the 
other 199 frames for the top five image features computed from the difference of prior and post-
treatment ultrasound images acquired on Day 3. These image features were computed from a 
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mouse within the HIFU+ELTSL treatment group. The results show the image features computed 
from different frames of ultrasound images acquired in one test are highly correlated or invariant.  
 
Figure 4-7. The GLN HL values computed from all mice under different treatments, which are 






















GLN HL 0.978 [0.951, 1.00] 0.125 
LGRE 0° 0.9668 [0.019, 0.917] 0.224 
Range HL 0.9491 [-0.058,0.608] 0.167 
LGRE LL 0.9719 [0.100, 0.978] 0.219 
Gradient STD LH 0.9513 [0.089, 0.905] 0.204 
 
4.4 Discussion 
In cancer research, many previous studies have reported to develop and apply either molecular 
biomarkers (i.e., [95-97]) or quantitative image markers (i.e., [46, 69, 70, 90, 98]) to predict tumor 
response to chemotherapies and/or other therapeutic methods at an early stage. In this study, I 
investigated and demonstrated the feasibility of identifying new quantitative image markers 
computed from ultrasound images. This study has a number of unique characteristics and potential 
impacts. First, in the previous studies, quantitative image markers were computed based on the 
Radiomics concept that uses CT and/or MRI images to predict cancer prognosis or tumor response 
to treatment [88]. In this study, I applied the Radiomics approach to ultrasound images to identify 
new quantitative image markers to predict cancer treatment efficacy. Due to ultrasound imaging's 
advantages as a diagnostic modality, developing highly performed and robust image markers could 
be a cost-effective approach in future research and clinical service. Second, thermal-based 
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therapies have been emerging as a promising cancer treatment method. However, accurate 
prediction aimed at determining the efficacy or treatment outcomes of different therapeutic 
approaches remains an unsolved challenge. This is the first study with a computer-aided approach 
to developing new quantitative imaging markers that can predict thermal therapies' efficacy using 
a mouse model. Third, I computed and compared image features of the longitudinal images 
acquired from prior and post-treatment ultrasound images and two-time points (Day 3 and Day 6 
after initial tumor cell embedment). As a result, I am able to conduct a more comprehensive data 
analysis and identify an optimal approach to extract and compute image markers in order to more 
accurately predict treatment efficacy or outcome at an early stage.      
From the experiments and data analysis results, I can make the following new observations. 
First, this study shows that it is possible to identify quantitative ultrasound image feature based 
markers at an early stage (i.e., Day 3 in this study) to predict thermal therapy efficacy. However, 
in the early stage, using the image marker computed from both prior and post-treatment ultrasound 
images can yield substantially higher prediction accuracy as compared to using the prior treatment 
images only (i.e., correlation coefficients of 0.375 vs. 0.679 as shown in Tables 3-3 and 3-5). This 
result is consistent with our earlier study of developing quantitative image markers computed from 
prior and post-chemotherapy CT images to predict ovarian cancer patients' response to 
chemotherapy in the clinical trials [70].  
Second, I observed that using quantitative image markers computed from the prior treatment 
ultrasound images acquired on Day 6 yielded substantially higher prediction power than the image 
markers computed from the prior treatment ultrasound images acquired on Day 3. The correlation 
coefficients increase from the moderate level to the strong positive level for both top five features, 
as shown in Table 3-3, and the same highly performed features shown in Table 3-4. Thus, the 
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trend is consistent, which indicates that the images acquired at the later stage (i.e., Day 6 in this 
study) contain higher discriminative information or predictive power to evaluate treatment 
outcomes.  
Third, I also observed a different phenomenon when using the image features computed from 
the difference between prior and post-treatment ultrasound images acquired on Day 3 and Day 6. 
Unlike the image markers computed on Day 3, adding post-treatment ultrasound images acquired 
on Day 6 does not further increase prediction power or have lower correlation coefficients, as 
shown in Table 3-6. It reveals that in the earlier day (Day 3), the tumors have higher positive 
responses to the thermal therapies than those on a later day (Day 6), which may indicate that at the 
later stage, tumors are more resistant to the treatment. Thus, the observation may clearly show that 
early treatment (i.e., on Day 3) is more important and effective than later treatment (i.e., on Day 6 
in this study), which is consistent with the established scientific evidence in cancer treatment 
research. 
Fourth, the computed image feature values also vary on the ultrasound images acquired from 
the mice under different treatment methods. In this study, 23 mice were treated with seven different 
thermal therapies. Based on the final tumor size measurement results or TSIR on Day 10, the 
effectiveness of these seven thermal methods has a monotonically decreased trend from thermal 
therapy method 1 (HIFU) to method seven (HIFU+E-LTSL). The computed image features also 
show a similar trend, as shown in Figure 3-7, which indicates the high correlation between the 
image features and thermal therapy methods. Thus, using quantitative image markers also has the 
potential to help identify optimal therapy methods.   
Last, although computer-aided detection schemes of medical images can be quite sensitive to 
change of image noise [99], I observed that image features computed from all image frames (i.e., 
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200 in this study) acquired at one ultrasound imaging test of a mouse were highly correlated or 
invariant to the small change of inherent image noise. As an example shown in Table 3-7, the 
mean correlation coefficients of the top five image features computed from the base image frame 
and other 199 image frames in one ultrasound imaging scan of a mouse ranged from 0.949 to 
0.978. The results revealed that as long as using a well-established or controlled imaging protocol, 
it is feasible to robustly compute quantitative image features from the ultrasound images for 
predicting the efficacy of tumor response to therapies. 
4.5 Conclusion 
Ultrasound is a safe, easy-to-use, and low-cost medical imaging modality. In this study, I 
investigated the feasibility of identifying and applying quantitative image feature based markers 
computed from ultrasound images using a C26 adenocarcinoma bearing mouse model to assess 
tumor response to thermal therapies. The study results demonstrated that ultrasound images 
acquired prior and post-therapy at an early stage (i.e., Day 3 of this study) contained useful and 
highly discriminative information that can possibly predict tumor response to therapies at an early 
stage. Although ultrasound images may have a higher inherent noise level than other medical 
imaging modalities (i.e., CT or MRI), this study also indicated the possibility of computing highly 
robust image features to develop robust image feature based markers. Thus, based on the 
preliminary results of this study, future studies using larger and more diverse image datasets are 
needed to further validate the performance and potential utility of this methodology and similar 
approaches.     
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Chapter 5: Applying A Novel Feature Selection Method To 
Optimize The Machine Learning Model For Peritoneal 
Metastasis Prediction In Gastric Cancer Patients 
 
5.1 Introduction 
While the incidence of gastric cancer has reduced recently, it remains the third leading cause 
of cancer-related death worldwide [100]. Despite the fact surgery remains the only therapeutic 
treatment option, preoperative neoadjuvant chemotherapy (NAC) has proven promising results 
with increased curative resection rates and improved survival [101]. In order to prevent the 
unfavorable effect of NAC, patients with different disease stages must be distinguished from each 
other [102] because, for each step of the disease, the treatment would be different [103]. Recent 
studies revealed that applying preoperative NAC for advanced gastric cancer patients with 
peritoneal metastasis (PM) yielded a much better clinical outcome and lead to a more significant 
overall survival rate [104, 105]. Therefore, an accurate assessment of the PM's existence is vital 
for selecting proper patients for undergoing NAC. Considering the overall accuracies of 
subjectively reading computed tomography (CT) and endoscopic ultrasound images are not 
entirely reliable [102, 103], an alternative technique is required to facilitate the assessment of 
tumor stages and the risk of PM.  
Recently, the novel radiomics technique has been applied in extracting quantitative 
information from medical images with a high dimensional image feature. Consequently, the data 
mining of the image feature pool suggests an efficient method to develop machine learning (ML) 
models and predict clinical outcomes [39, 88]. While numerous radiomics based ML models have 
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been reported to differentiate and stage gastric cancer patients [106, 107], these studies extracted 
radiomics features from the tumor region that is segmented manually from one CT slice chosen by 
the radiologist. Hence, the correlation analysis based method was used to determine a small set of 
image markers, which cannot eliminate the redundant features. Therefore, the discriminatory 
power and prediction accuracy of these ML models were inadequate. To overcome such 
restrictions, in this study, I propose to develop a new computer-aided detection (CAD) scheme in 
order to predict the risk of PM among gastric cancer patients. First, our scheme segments 
automatically gastric tumor volume in 3D CT image data, leading to better calculating image 
features related to the heterogeneity of the gastric tumors. Second, to decrease feature space 
dimensionality and better ascertain non-redundant image features from a large initial pool of 
extracted radiomics features, I examine and apply a random projection algorithm (RPA). Third, to 
prevent bias in feature vector generation, RPA is embedded in a multi-feature fusion-based 
machine learning (ML) model for prediction of the PM risk, which is trained and tested using (1) 
a synthetic minority oversampling technique (SMOTE) and (2) a leave-one-case-out (LOCO) 
cross-validation method. The details of the study, including experimental measures, data analysis 
results, and discussions, are presented in the following sections of this chapter.   
5.2 Materials and Methods 
5.2.1 Image Dataset 
 
In this study, I retrospectively use a dataset of abdominal computed tomography (CT) images. To 
prevent potential case selection bias, the dataset initially includes 219 consecutive patients 
diagnosed and treated with gastric cancer. Afterward, by eliminating the unresectable or 
undetectable cases based on CT examinations and poor image quality as verified by the 
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radiologists in the retrospective review, 159 cases are involved in this study dataset. Among these 
cases, 121 patients have PM, and 38 patients do not have PM. Table 5-1 summarizes the 
distribution of overall demographic information and related clinical results of these 159 gastric 
cancer patients in this dataset. 
Table 5-1. The overall demographic information and related clinical results of patients in the 
dataset. 
 Category Cases with PM Cases without PM 
Total Cases  121 38 
Age (years old) 
< 45 
45 – 65 
> 65 

































37 (23.2%) 19 (11.9%) 
20 (12.6%) 7 (4.4%) 
50 (31.4%) 12 (7.5%) 




I              0 38 (23.9%) 
II 26 (16.4%) 0 
III 32 (20.1%) 0 
IV 63 (39.6%) 0 
Bormann Type 
1 1 (0.6%) 0 
2 21 (13.2%) 11 (6.9%) 
3 94 (59.1%) 25 (15.7%) 
4 5 (3.1%) 2 (1.3%) 
 
Each patient has undergone an abdominal CT imaging examination during the original cancer 
diagnosis before surgery. All CT examinations were carried out using a multidetector CT machine 
(GE Discovery CT750 HD; GE Revolution CT, GE Healthcare). Each patient is asked to be fast 
from food overnight and drank 600-1000 ml water to distend the stomach before the CT 
examination. The contrast-enhanced CT images are taken a delay of 28 s (arterial phase), 55 s 
(portal phase), and 120 s (venous phase) after administration of infused 1.5 ml/kg body weight 
iodinated contrast agent (Optiray 320 mg I/mL, Bayer Schering Pharma) intravenously at a flow 
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rate of 2.5 ml/s. The CT scanning parameters include (1) tube voltage switching between 120 kVp 
and 140KVp in spectral imaging mode, (2) tube current automatically augmenting with the 
maximum limit of 200mA, (3) tube rotation time of 0.76 – 0.80s, (4) detector collimation of 64 × 
0.625 mm, (5) field of view with 350 – 500 mm, and (6) the image matrix with 512 × 512 pixels 
and reconstruction thickness of 2.5 mm. 
5.2.2  Tumor Segmentation 
By identifying the heterogeneity of tumors in the clinical images, I improved and applied a 
hybrid tumor segmentation scheme that utilized a dynamic programming method [108, 109] to 
identify growing thresholds of a multi-layer topographic region growing algorithm adaptively and 
primary contour in active contour algorithm. In particular, the tumor segmentation scheme 
contains the following steps; First, a Weiner filter is used to lessen image noise. Second, a primary 
seed is placed at the center of the tumor region of a CT slice in which the tumor has its largest 
area. To decrease inter-operator variability in selecting the initial seed and improve the robustness 
of segmentation results explained in the previous study [110], a predefined window with the size 
of (5,5) around the initial seed is automatically generated. A pixel with the minimum value within 
the window is identified and selected as the initial seed point. Third, to automatically define the 
first threshold value for the region growing algorithm, a new predefined window with size of (5,5), 
which confirms to fully locate inside all tumor regions of our dataset and prevent potential risk of 
growing leakage at the first growth layer, is generated around the new seed point. Subsequently, 
the scheme calculates the pixel value differences between the center pixel and boundary pixels and 
detects the maximum difference. Consequently, the region growing threshold is defined as 𝑇1 =
𝑉𝑐 + 0.25 × 𝐷𝑚𝑎𝑥, where 𝑉𝑐 is the central pixel value and 𝐷𝑚𝑎𝑥 is the calculated maximum pixel 
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value difference inside the bounding window. This threshold value is applied to determine the first 
layer of region growing to segment the tumor region, depicting on one CT image slice. 
Fourth, after defining the first layer of tumor region growth, the growing threshold of the 
second layer is computed by 𝑇2 = 𝑇1 + 𝛽𝐶1 where 𝐶1 is the constant value of the first layer, and 
𝛽  is a coefficient (i.e., 0.5). This multi-layer region growing algorithm continues to grow until the 
growing ratio between two adjoining layers is bigger than two times the last layer's size. Finally, 
after the region growing algorithm stops, the scheme chooses the boundary contour of the last 
region growing layer as the initial region contour. The active contour algorithm is followed to 
expand or shrink the contour curve for the best fitting tumor boundary.   
Figure 5-1 and Figure 5-2 show the block diagram of this tumor segmentation scheme and an 





   











   
(a) Selecting the initial 
seed 
(b) Applying region 
growing based on auto 
threshold 
(c) Continuing to grow 
till meeting the growth 
criteria 
   
  
 
(d) Growing until the 
criteria of the growth do not 
meet 
(e) Final segmentation  
Figure 5-2. The process of 2D tumor segmentation. 
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Subsequently, after tumor region segmentation on one CT slice, the CAD scheme continues to 
apply tumor region segmentation by scanning in both up and down directions until no tumor region 
is found in the next adjacent CT slice. In this progression, the tumor region’s central point detected 
in the adjacent CT slice is mapped into the new CT slice as the initial region growing seed. After 
that, the tumor region segmentation in this targeted slice is automatically performed from the 
mapped growing seed. Moreover, a tumor growing boundary condition is restricted by the adjacent 
slice to facilitate the multi-layer region-growing process and prevent growth leakage.  
Figure 5-3 displays an example of tumor regions' segmentation showing several CT image 
slices of one case. In this way, 3D tumor volume can be segmented and computed.   
   
Figure 5-3. An Example of 3D segmentation of a tumor region in 3 different slices. 
5.2.3 Feature Extraction  
 
Once 3D tumor volume is segmented, the CAD scheme is applied to compute a large pool of 
radiomics-based image markers, including 315 features extracted from each segmented 2D tumor 
region (ROI) illustrating on one CT image slice. These features were considered into four main 
groups, including (a) the grayscale-run length (GLRLM) features in which 44 two-dimensional 
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features are computed. (b) The Gray Level Difference Methods (GLDM) probability density 
function (PDF) features in which four features of mean, median, standard deviation, and variance 
from each probability density function representing statistical texture features of ROI are 
computed. (c) Wavelet domain features in which the image is first decomposed into four main 
components consist of low and high scale decomposition by wavelet transform [111]. Then, the 
GLCM features [112], as well as 21 tumor density [113] and GLDM features [114], are extracted 
from those components. (d) Laplacian of Gaussian (LoG) features in which a Gaussian smoothing 
filter is first applied to lessen the sensitivity to the noise, and next, the Laplacian filter sharpens 
the image's edge and highlights rapid intensity changes inside the region [115]. Following that 
from the extracted points after applying the LoG filters, the mean, median, and standard deviation 





Figure 5-4. Flow Diagram of Feature extraction Method. 
Following the 2D features’ computation of all segmented tumor regions in 𝑁 involved CT 
image slice, CAD scheme computes each 3D feature (𝐹3𝐷
𝑘 ) as:  
𝐹3𝐷
𝑘 = ∑ 𝑚𝑖 × 𝐹2𝐷
𝑘𝑁
𝑖=1                                                                                                                                 (5-1) 
In which 𝑚𝑖 is the ratio of the tumor volume segmented on a 𝑖th CT slice to the whole 
segmented tumor volume on all 𝑁 involved CT slices. The tumor volume segmented on a 𝑖 th slice 
is computed by multiplying the segmented region size (2D) to the CT slice thickness. Lastly, all 
315 computed 3D feature values are normalized between 0 to 1 to decrease case-based reliance, 




























5.2.4 Feature Reduction Using Random Projection Algorithm 
 
Since the initial feature pool consists of 315 image features, many of them can be irrelevant 
(with lower performance) or redundant (highly correlated). Therefore, choosing a small set of 
optimal features to reduce the feature dimension and increase learning accuracy is essential. This 
study explores and applies a novel image feature regeneration method of the Random Projection 
Algorithm (RPA). Theoretic analysis has shown that the RPA has advantages for its simplicity, 
high performance, and robustness in comparison with other feature reduction methods; however, 
empirical results are sparse [50]. Meanwhile, RPA has been investigated and tested in many 
engineering applications such as text [116] and face and object recognition [117] and yielded 
comparable results to conventional feature regeneration methods like principal component analysis 
(PCA) [118]. Nonetheless, the advantage of applying RP methods over their alternative is that they 
generate more robust results and computationally inexpensive [50, 119].  
This study will employ RPA to generate optimal image features from the original large set of 
radiomics features. Following is a brief introduction of the RPA method. By taking into account 
each case as a point in a k dimensional space, where k represents the number of image features, 
the Euclidian distance between two points can be defined as follows:  
|𝑀 − 𝑍| = √∑ (𝑚𝑖 − 𝑧)2
𝑘
𝑖=1                                                                                                       (5-2) 
Considering Formula (2), 𝑀 = (𝑚1, … , 𝑚𝑘), and 𝑍 = (𝑧1, … 𝑧𝑘) are two points in the k 
dimensional space. Similarly, the volume of a sphere with radius r and volume of V in k 
dimensional space is expressed as follows in Formula 5-3 [120]: 
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                                                                                                                                               (5-3) 
The normalization of the feature matrix between [0, 1] proposes that all data can be involved 
in a sphere with a radius of 1. The vital fact about a sphere with a unit radius is that the more 
enhancement in dimension, the more reduction in the volume (Formula 5-4). Concurrently, the 













) ≅ 0                                                                                                                                         (5-4) 
Furthermore, regarding the theory of the heavy-tailed distribution, for a case like 𝑀 =
(𝑚1, … , 𝑚𝑘) in the space of features, considering features independent with a satisfactory 
approximation, or roughly perpendicular variables mapping to different axes, with 𝐸(𝑚𝑖) = 𝑝𝑖, 
∑ 𝑝𝑖 = 𝜇
𝑘
𝑖=1  and 𝐸|(𝑚𝑖 − 𝑝𝑖)
𝑑| ≤ 𝑝𝑖 for 𝑑 = 2,3, … , ⌊𝑡
2/6𝜇⌋, then, a probability can be calculated 
using Formula 5-5 [120]: 
𝑝𝑟𝑜𝑏(|∑ 𝑚𝑖 − 𝜇
𝑘
𝑖=1 | ≥ 𝑡) ≤ 𝑀𝑎𝑥 (3𝑒
−𝑡2
12𝜇, 4 × 2
−𝑡
𝑒 )                                                                          (5-5) 
The more the value of t surges, the less chance of a point be out of that distance. Hence, 𝑀 
should be focused on the mean value. Specifically, according to Formula 5-4 and Formula 5-5, 
with a reasonable estimation, all data are contained in a sphere of unit size, and they are focused 
around their mean value. As a result, if the dimension increases, the volume of the sphere would 
close to zero. Consequently, the difference between the cases is not enough for precise 
classification. 
According to the aforementioned analysis, the larger the initial feature vector size, the bigger 
the space dimension is. Hence, most of the data is focused around the center, which leads to less 
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difference between the features. Consequently, to reduce the feature dimension, an efficient 
technique is the one that reduces the features’ dimensionality while preserves the distance between 
the points, representing rough preservation of the vast amount of information. Suppose we apply 
a conventional feature selection method and accidentally select a d-dimensional sup-space of the 
initial feature vector. In that case, it is expected that all the projected distances in the new space 
are within a determined scale-factor of the initial k-dimensional space [121]. Accordingly, it is 
feasible that after removing the redundant features, the accuracy would not improve due to the fact 
that the divergence between the points is not significant enough to consider as a robust model. 
To address the aforementioned concern and improve the feature space, Johnson-Lindenstrauss 
Lemma's theory can be applied in RPA [122]. This theory expresses that for any 0 < 𝜖 < 1, and 
for any number of cases as 𝑡, which are like the points in 𝑘-dimensional space (𝑅𝑘), if assuming 










                                                                                                                                               (5-6) 
Afterward, for any set 𝑊 of 𝑡 points in 𝑅𝑘, for all 𝑧, 𝑤 ∈ 𝑊, it is shown that there is a map, 
or random projection function like 𝑓: 𝑅𝑘 → 𝑅𝑑, which keeps the distance defined by Formula 5-
7 [122]: 
(1 −  𝜖)|𝑧 − 𝑤|2 ≤ |𝑓(𝑧) − 𝑓(𝑤)|2 ≤ (1 + 𝜖)|𝑧 − 𝑤|2                                                          (5-7) 
The above calculation also can be achieved from Formula 5-8 as follows [122]: 
|𝑓(𝑧)−𝑓(𝑤)|2
(1+ 𝜖)
≤ |𝑧 − 𝑤|2 ≤
|𝑓(𝑧)−𝑓(𝑤)|2
(1−𝜖)
                                                                                                 (5-8) 
As demonstrated in Formula 5-8, the distance between the set of points in the lower-dimension 
space is nearly close to the distance in high-dimensional space. The Lemma theory asserts that it 
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is viable to project a set of points from a high-dimensional space into a lower-dimensional space, 
as the distances between the points are roughly preserved. 
As a result, the above analysis proposes that if the initial set of features are projected into space 
with a lower-dimensional subspace using the random projection method, the distances between 
points are maintained under better contrast. Thus, it may enhance the classification accuracy 
between the features of two classes representing cases either with or without PM under low risk 
of overfitting ML models.  
In this study, I also explore whether using RPA can yield a better result in comparison to 
several commonly used feature dimensionality reduction methods applied in the medical imaging 
informatics field, such as principal component analysis (PCA) [123], maximum relevance, and 
minimum redundancy (MRMR) [124], recursive feature elimination (RFE) [125], and least 
absolute shrinkage and selection operator (LASSO) [126]. All features extracted in the above 
section are fed into different methods of RPA, PCA, LASSO, MRMR, and RFE. Each method 
produces 20 optimal features out of the initially large set of 315 features. 
5.2.5 Developing Machine Learning Model 
 
To classify the study cases with or without PM, I build a multi-feature fusion-based machine 
learning model. Nevertheless, due to the unbalance dataset, which contains 121 PM cases and 38 
non-PM cases, I employ a synthetic minority oversampling technique (SMOTE) algorithm [127] 
to rebalance the original image dataset. The advantages of using SMOTE to develop machine 
learning models in medical images have been well explored and verified in many previous studies 
(including those conducted by researchers in our lab) [90, 128, 129]. In this study, I apply the 
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SMOTE method to create 83 synthetic non-PM cases. Hence, the dataset is enlarged to 242 cases, 
including 121 PM cases and 121 non-PM cases. 
After dealing with the imbalance dataset, I choose and apply the Gradient Boosting Machine 
(GBM) to train an optimal machine learning model to predict the risk of advanced gastric cancer 
patients suffering from having PM. The GBM model is a popular machine learning algorithm that 
has proven efficient in classifying complex datasets and often first in class with predictive accuracy 
[130]. Regarding hyperparameter tuning, the GBM model is implemented to achieve a low 
computational cost and high robustness in detection results as well. Moreover, to reduce the case 
partition and feature selection (or generation) bias, I apply a leave-one-case-out (LOCO) based 
cross-validation method to train and test the GBM model. In each LOCO cycle, PRA and SMOTE 
are embedded in the training process. Afterward, one case not involved in the training cycle is 
tested by the GBM model trained using all other cases in the dataset. The model generates a 
prediction score for each testing case ranging from 0 to 1. A higher score specifies a higher risk of 
PM. The prediction performance is assessed using a receiver operating characteristic (ROC) 
method after discarding all SMOTE generated non-PM training samples. The areas under ROC 
curves (AUC) and overall prediction accuracy after applying an operating threshold (𝑇 = 0.5) on 
the GBM model produced prediction scores are used as two performance evaluation indices. 
Furthermore, Cohen’s Kappa coefficient value is also computed for evaluating the performance of 
the CAD scheme. High Cohen’s Kappa coefficient value (ranging from zero to one) explains high 
robustness and less randomness in the predicted results [41, 131].  
In summary, Figure5-5 displays a complete flow chart using our CAD scheme to process 
images, compute optimal features, and train the GBM model in which the RPA and SMOTE are 
embedded inside the LOCO process. In this study, the segmentation and feature extraction steps 
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were performed using the MATLAB R2019a package, and the feature reduction and classifications 
were made using Python 3.7. 
 
 
Figure 5-5. The flowchart of the CAD scheme proposed in this study. 
 
5.3 Results 
Figure 5-6 presents five ROC curves created by the GBM models embedded with five different 
feature reduction methods (LASSO, PCA, RFE, RPA, MRMR). Table 5-2 illustrates the 
performance comparison between using RPA and the other four feature selection methods. The 
AUC value and the overall prediction accuracy of the GBM model trained using RPA with 3D 
image features as input are 0.69±0.019 and 71.2%, respectively. Besides, the precision, sensitivity, 
and specificity of the proposed method are 65.78%, 43.101%, and 87.12%, respectively. The 
results show that using RPA leads to produce an optimal image feature vector that can build a 
GBM model with substantially higher prediction accuracy (p < 0.05) than using the GBM models 


























Figure 5-6. Comparison of five different ROC plots generated using GBM models optimized 
using five feature reduction and selection methods. 
 
Table 5-2. The performance evaluation of five GBM models optimized using five different 
feature reduction and selection methods. 
 Precision Sensitivity Specificity Accuracy AUC 
LASSO 38.9% 31.1% 80.0% 65.8% 0.59±0.013 
PCA  38.5% 64.1% 65.5% 65.2% 0.58±0.021 
RFE 56.5% 62.5% 51.2% 56.9% 0.60±0.020 
MRMR 50.0% 32.7% 82.0% 64.5% 0.60±0.017 




Figure 5-7 demonstrates two ROC curves, and Table 5-3 presents the prediction performance 
values to compare two GBM models trained using 2D features computed from the largest tumor 
region segmented from one CT image slice and the 3D features computed from the segmented 
tumor volumes. In these two GBM models, the RPA method is used to choose and generate optimal 
feature vectors. The results show that using 3D image features yields considerably higher 
performance than using 2D features (p < 0.05) in predicting the risk of gastric cancer cases with 
PM.  
Table 5-3. The comparison of two GBM model performances between using 2D and 3D image 
features produced using the RPA method. 
 AUC Accuracy 
2D features 0.66±0.017 68.4% 






Figure 5-7. The comparison of two ROC plots produced by two GBM models optimized using 
2D and 3D features generated using the RPA method, respectively. 
Additionally, I also build and compare several other types of ML models, consisting of logistic 
regression, random forest, support vector machine (SVM), and decision tree. All models are 
trained and tested by the same LOCO cross-validation method embedded with RPA and SMOTE 
schemes. Table 5-4 and Figure 5-8 show the results to compare the prediction performance of 
five different ML models, which indicates that GBM yields the highest accuracy than the other 
four ML models. However, AUC values between GBM, SVM, and logistic regression-based ML 




Table 5-4. The comparison of prediction performance of five different ML models. 
 AUC value Accuracy 
SVM 0.66 64.55% 
Logistic Regression 0.68 61.93% 
Random Forest 0.63 69.03% 
Decision Tree 0.56 65.16% 









CT is the most popular imaging modality to detect and diagnose different types of abnormality, 
such as gastric cancer, and it may also offer a non-invasive alternative method to predict the risk 
of PM in advanced gastric cancer patients. Regardless of the potential advantages of using CT to 
detect or predict the risk of PM, the effectiveness of radiologists in reading and interpreting CT 
images for PM detection is inadequate [132]. While studies have proposed that developing and 
applying CAD schemes combined with the radiomics concept and ML model is useful and may 
offer radiologists a second opinion to more accurately detect and diagnose different abnormalities 
[5], developing ML models using a large pool of radiomics features and small training dataset 
remains an arduous task. In this study, I examine a new approach to develop a new CAD scheme 
or ML model with several exceptional characteristics and novel ideas in feature extraction and ML 
model optimization to enhance accuracy in detecting advanced gastric patients with PM. 
     First, in a previous study, the authors carried out the manual segmentation of gastric cancer 
tumor regions from the single CT image slices [133]. Nevertheless, manual segmentation of tumor 
regions is often inconsistent with large inter-observer variability due to the fuzzy boundary of the 
tumor regions, which makes the computed image features also unreliable or not reproducible. 
Therefore, the prediction accuracy may be affected or not robust. To address this issue, in our 
study, I developed a new interactive CAD scheme with a graphical user interface (GUI) to initiate 
the segmentation of tumor regions from CT images. A user only requires placing an initial seed 
around the center of the tumor region with the largest area size in one CT slice. The CAD scheme 
then segments tumor regions on all involved CT image slices automatically. The segmentation 
results can also be visualized by the human eyes on the GUI window. Although I have designed 
and installed a correction function in the GUI and the operator can activate this function to order 
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CAD scheme correcting the segmentation errors (if any), the results in this study demonstrate that 
the CAD scheme can achieve satisfactory results on automatic segmentation of all 3,305 tumor 
regions from all 159 cases in our dataset. 
    Second, although the previous study [134] has suggested developing a radiomics based ML 
model to detect and diagnose gastric cancer using CT images, in that study, the Authors employ 
image features computed just from one manual selected CT image slice, which may not accurately 
represent image features of the entire tumor. To solve this issue, I conduct the first study that 
develops and tests a new ML model using 3D extracted image features. Our study results support 
our hypothesis that using 2D image features extracted from only one CT slice is not adequate 
enough to represent the heterogonous characteristics of the tumors while applying 3D image 
features can yield significantly higher prediction performance. In particular, in this study, I have 
performed 3D tumor segmentation and extracted 3D image features to detect or predict advanced 
gastric patients' risk of having PM. As revealed in Table 5-3, the prediction performance of the 
GBM model trained using 3D features yields AUC=0.69±0.019 and an accuracy of 71.2%, which 
are notably higher than the GBM model trained using 2D features with AUC=0.66±0.017 and the 
accuracy of 68.4% (p < 0.05), respectively. 
      Third, in developing CAD schemes to train ML models, identifying a small and effective 
set of image features plays an important role [135, 136]; thus, in previous studies, different feature 
dimensionality reduction methods have been investigated [137, 138]. Although these studies made 
noticeable progress in optimizing the feature vectors, there is a substantial challenge of achieving 
small feature vectors representing the complex and non-linear image feature space. In this study, 
I explore the viability of applying the RPA to the medical imaging informatics field in optimizing 
the CAD scheme or ML model. Our study results reveal that RPA is a promising technique to 
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reduce the dimensionality of a set of points lying in Euclidian space for very heterogeneous feature 
data, which commonly occurs in medical images and has advantages to attain high robustness in 
classification and low risk of overfitting. Figure 5-6 shows that the prediction performance of the 
GBM model embedded with RPA yields substantially higher performance than other GBM models 
embedded with the other four popular feature reduction methods (PCA, LASSO, MRMR, and 
RFE). As presented in Table 5-2, the AUC value after applying the RPA reached the highest 
prediction accuracy of 71.2% than the other four feature reduction methods. Moreover, the 
computed Cohen’s Kappa coefficient value is 0.68, which specifies the reliability or robustness of 
the GBM model optimized using the RPA method.  
Fourth, since many ML models have been developed and used in medical imaging informatics 
or CAD fields, choosing which ML model can also be a challenging issue. In this study, I also 
evaluate the prediction performance of five popular ML models. The results demonstrate that many 
different ML models can yield very comparable performance, as shown in Table 4 and Figure 8. 
However, considering the data presented in Table 5-2, I can find that selecting or generating 
optimal features plays a more essential role or contribution than choosing a different ML model. 
Thus, combining the above new observations of this study, I validate that due to the very 
complicated distribution of radiomics features extracted from medical images, RPA is a promising 
and more powerful technique applicable to generate optimal feature vectors for better training ML 
models used in CAD schemes of medical images. 
This is a valid proof-of-concept study that indicates a new and promising approach to identify 
and generate optimal feature vectors for training ML models implemented in CAD schemes of 
medical images. Since optimizing the feature vector is one of the essential steps of building an 
optimal ML model using the radiomics concept, the proposed method in this study is not only 
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limited to the detection of advanced gastric patients with PM, and it can also be beneficial for other 
medical imaging studies of developing ML models to detect different types of cancers or 


















Chapter 6: Summary and Future Work 
6.1 Summary 
Computer-aided detection schemes have been developed and are currently widely employed 
as a second reader in many medical facilities. 
In the previous chapters of this dissertation, I presented different studies that I have done during 
my Ph.D. In chapter 1, I have discussed the CAD concept, application, and also challenges in 
developing current CAD schemes. In chapter 2, I expressed the overall objective of this 
dissertation as well as each of my studies’ hypotheses and motivations.  
As discussed in chapter 3, my first study's purpose was to use the false-positive generated by 
the CAD schemes to predict the short-term breast cancer risk [46]. In that study, I hypothesized 
that the false positives generated by the CAD schemes are not harmful and may be beneficial to 
extract some useful information to predict the cancer risk. To test that hypothesis, I have used a 
relatively large dataset and used a previously developed CAD scheme in our lab to extract new 
quantitative features from the CAD-generated false positive to predict the short-term breast cancer 
risk. The study showed the promising results of using the new extracted features in breast cancer 
risk prediction.  
Following that study, In chapter 4, I have presented my second study for predicting the 
treatments’ efficacy in reducing cancer tumor size [113]. In that study, I hypothesis that the image 
features extracted from the ultrasound images could be valuable in evaluating the treatments’ 
performance in reducing the tumor size. For this study, an image dataset involving ultrasound 
images of 23 athymic nude mice bearing C26 mouse adenocarcinoma cell tumors was assembled. 
These mice were divided into seven groups and treated using seven thermal therapy methods, 
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respectively. Additionally, I have developed a CAD scheme to conduct tumor segmentation and 
feature analysis. The study demonstrated the feasibility of extracting new quantitative image 
features from ultrasound images to assist the early assessment of tumor response to therapies.  
In Chapter 5, I have reported my last study [139] in investigating a new method to optimize 
the ML model for predicting PM in gastric cancer patients. This study's hypothesis was that by 
applying a new feature reduction method named RPA, the ML model's accuracy in predicting PM 
could be enhanced. We assemble a retrospective dataset involving abdominal computed 
tomography (CT) images acquired from advanced gastric cancer patients. A computer-aided 
detection (CAD) scheme is then developed and applied to segment the gastric tumor area and 
computes image features. The study showed that CT images of the gastric tumors contain 
discriminatory information to predict PM's risk in gastric cancer patients, and RPA is a promising 
method to generate optimal feature vectors to improve ML models' performance. 
6.1.1 The Contributions of My Ph.D. Research Work 
 
1- I introduced new quantitative image features and used the false-positive results generated 
by the CAD schemes. Due to this study's novelty and unique characteristics, it was selected 
as a featured article in the journal of Physics and Medicine in Biology in 2018. 
2- I extracted quantitative features from ultrasound images to predict treatment’s efficacy, 
which has not been investigated before my study. 
3- I applied a new feature reduction method to select the optimal features from the large initial 
pool of features for the first time in the medical imaging field. 
4- I proposed a new method to segment the cancer tumor volume automatically. 
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5- I developed several interactive CAD schemes with a graphic user interface to increase 
transparency, assist users in better understanding CAD schemes' results, and enhance users' 
confidence (clinicians) to consider and accept CAD-generated results.  
Through my studies, we have published several journals and conference papers, and peer-
reviewed abstracts, as shown in the following section in which I was either first or co-author. 
In Summary, in addition to the publications, one of my research work's significant 
contributions is that I have collaborated with clinicians in OUHSC and developed CAD schemes 
with GUI by which they developed promising cancer studies, and their results have been reported 
in independent studies. Hence, my research studies demonstrated the feasibility of developing 
novel quantitative imaging analysis schemes based on machine learning for cancer research. 
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6.2 Future Studies 
Despite the encouraging results of recent studies in imaging analysis schemes, it still suffers 
from some limitations that needed to be explored in future studies. For instance, most developed 
schemes are suffering from proper and highly accurate automatic segmentation of the region of 
interest, which leads to inaccurate feature selection and finally affects the classifications' accuracy. 
Apart from the segmentation step, as previously mentioned, other imaging analysis schemes such 
as feature extraction, feature selection, and classification are required to be improved. Hence, these 
areas have been attracting many research interests and need further investigations in future studies. 
Furthermore, in the following paragraphs, I want to briefly mention some limitations in each of 
my studies which can be addressed and evaluated in future studies. 
Although my first study had several unique characteristics, it also had some limitations. First, 
while I used a relatively large dataset involving 1,044 mammography screening cases, it has a very 
high cancer prevalence ratio (402 vs. 642), which does not represent the cancer prevalence ratio in 
the real mammography screening environment. Instead, this is just a laboratory-based retrospective 
study. This approach's potential clinical utility and/or new imaging marker need to be validated in 
future prospective studies. Second, this study only focuses on predicting the risk of developing 
mammography-detectable cancer in the subsequent screening. Although detection or distinction 
between invasive (or aggressive) and non-invasive cancer is an important clinical issue and 
research topic in reducing over-diagnosis and over-treatment, whether we can develop a new 
clinical marker or model based on CAD of mammograms to help solve this issue has not been 
investigated in this study. Third, I only extracted four simple features from the CAD-generated 
detection results and selected a simple multinomial logistic regression model. To further advance 
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risk prediction performance, more studies are needed to continue exploring, identifying, or 
developing more effective imaging markers from the CAD-generated detection results and their 
impact on future breast cancer risk.   
As for my second study, despite the promising data analysis results and observations, this was 
a preliminary study with limitations. For example, Althoughin this study, I only used a small 
dataset including 23 athymic nude mice, which were divided into seven groups treated with seven 
different thermal therapies. The ultrasound images were acquired by one group of researchers in 
one research laboratory. Thus, in order to validate the study results and enhance the feasibility of 
developing robust image feature based markers to predict cancer treatment efficacy, more studies 
are needed by using larger and diverse datasets from both prior clinical (using mouse models) and 
clinical (using real patient images) researches in the future.  
Regardless of my last study's encouraging results, I also notice some limitations in the 
presented study. First, the dataset used in my study is moderately small; therefore, to validate this 
study's results, larger datasets are essential before being tested in future prospective clinical 
studies. Second, despite the fact that in this study, I have used synthetic data to balance the dataset 
and reduce the impact of an imbalanced dataset, applying the SMOTE technique is just sufficient 
for the low dimensional data, and it may not be appropriate or optimal for high dimensional data 
[140]. Third, in the large initial set of features, I only extracted a limited number of 315 statistics 
and textural features, which are much less than the number of features extracted and computed 
based on recently developed radiomics concepts and technology in other studies [141]. Hence, 
more texture features can be investigated in future studies to enhance the diversity of the initial 
feature pool, which may also increase the chance of selecting or generating more optimal features 
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to substantially improve the ML model's accuracy to predict the risk of PM. To address the above 
limitations, more studies and progress are needed in this field. 
Appendix І 
7.1 The Gray Level Co-Occurrence Matrixes (GLCM) Features  
Texture features were calculated using the GLCM. The results are nine texture parameters. 
Suppose GLCM is defined as Cij. The angular second moment, inertia, inverse difference moment, 
entropy, correlation, sum average, difference average, sum entropy, Contrast, the sum of squares 
variance, sum variance, difference variance, and difference entropy are computed as follows: 
 
1- The angular second moment 















3- Inverse difference moment 
𝑇3 = ∑ ∑
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6- Sum average 




7- Difference average 




8- Sum entropy 






9- Difference entropy 
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12- Sum variance 





13- Difference variance 𝑇13 = 𝑣𝑎𝑟𝑖𝑎𝑛𝑐𝑒 𝑜𝑓 𝐶(𝑥−𝑦) 
 
7.2 Gray Level Run Length Matrix-based features (GLRLM) 
Gray-level run-length matrix-based features, as defined by [142]. Assume (i,j)th entry in the 
given run-length matrix is P(i,j), the number of different run-length is Nr, the number of discrete 
intensity value in the image is Ng, the number of voxels in the image is Np, and the entry (i,j) of 
the normalized GLRLM is described as: 
𝑝(𝑖, 𝑗) =
𝑝(𝑖, 𝑗)






         









2- Long Run Emphasis (LRE) 






3- Gray level Non-Uniformity (GLN) 









4- Run Length Non-Uniformity (RLN) 








5- Run Percentage (RP) 



















7- High Gray Level Run Emphasis 
(HGRE) 







































11- Long Run High Gray Emphasis 
(LRHGE) 
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